Naar www.iknl.nl
- Gastroenterologie > Oesofaguscarcinoom
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline
----------

Laatst gewijzigd : 2015-01-05, Versie: 3.1, Verantwoording: Nederlandse Vereniging van Maag-Darm-Leverartsen, Type: Landelijke richtlijn

Referentielijst

1 - Lerut T
Lerut T, Coosemans W, Decker G, Leyn P de, Nafteux P, Raemdonck D van. Cancer of the esophagus and gastro- esophageal junction: potentially curative therapies. Surg Oncol 2001;10:113-22.
 
2 - Wijnhoven BP
Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro- oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002;14:115-22.
 
3 - Visser O
Visser O. Incidence of cancer in the Netherlands 1998: tenth report of the Netherlands cancer registry. 2002.
 
4 - Bollschweiler E
Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of eso- phageal adenocarcinoma in white males. Cancer 2001;92:549-55.
 
5 - Vizcaino AP
Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002;99:860-8.
 
6 - Wijnhoven BP
Wijnhoven BP, Louwman MWJ, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro- oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002;14:115-22.
 
7 - Botterweck AA
Botterweck AA, Schouten LJ, Volovics A, Dorant E, Brandt PA den. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-54.
 
8 - Devesa SS
Devesa SS, Blot WJ, Fraumeni J-FJ. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53 .
 
9 - Powell J
Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002;102:422-7.
 
10 - Siesling S
Siesling S, Dijck JAAM van, Visser O, Coebergh JWW. Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998.
 
11 - Adami HO
Adami HO, McLaughlin JK, Hsing AW, Wolk A, Ekbom A, Holmberg L, et al. Alcoholism and cancer risk: a population- based cohort study. Cancer Causes Control 1992;3:419-25.
 
12 - Baron AE
Baron AE, Franceschi S, Barra S, Talamini R, Vecchia C la. A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 1993;2:519-23.
 
13 - Brown LM
Brown LM, Silverman DT, Pottern LM, Schoenberg JB, Greenberg RS, Swanson GM, et al. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control 1994;5:333-40 .
 
14 - Castellsague X
Castellsague X, Munoz N, Stefani E de, Victora CG, Castelletto R, Rolon PA, et al. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 1999;82:657-64.
 
15 - Gao YT
Gao YT, McLaughlin JK, Blot WJ, Ji BT, Benichou J, Dai Q, et al. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 1994;58:192-6.
 
16 - Tavani A
Tavani A, Negri E, Franceschi S, Vecchia C la. Risk factors for esophageal cancer in women in northern Italy. Cancer 1993;72:2531-6.
 
17 - Wu CH
Wu CH, Hsiao TY, Ko JY, Hsu MM. Dysphagia after radiotherapy: endoscopic examination of swallowing in patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000;109:320-5.
 
18 - Launoy G
Launoy G, Milan C, Faivre J, Pienkowski P, Gignoux M. Tobacco type and risk of squamous cell cancer of the oeso- phagus in males: a French multicentre case-control study. Int J Epidemiol 2000;29:36-42.
 
19 - Zambon P
Zambon P, Talamini R, Vecchia C la, Maso L dal, Negri E, Tognazzo S, et al. Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northern Italy. Int J Cancer 2000;86:144-9.
 
20 - Zhang ZF
Zhang ZF, Kurtz RC, Sun M, Karpeh MJ, Yu GP, Gargon N, et al. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996;5:761-8.
 
21 - Menke-Pluymers MB
Menke-Pluymers MB, Hop WC, Dees J, Blankenstein M van, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993;72:1155-8.
 
22 - Engel LS
Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1404-13.
 
23 - Bosetti C
Bosetti C, Franceschi S, Levi F, Negri E, Talamini R, Vecchia C la. Smoking and drinking cessation and the risk of oesophageal cancer. Br J Cancer 2000;83:689-91.
 
24 - Bosetti C
Bosetti C, Vecchia C la, Talamini R, Simonato L, Zambon P, Negri E, et al. Food groups and risk of squamous cell esophageal cancer in northern Italy. Int J Cancer 2000;87:289-94.
 
25 - Brown LM
Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, et al. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995;87:104-9.
 
26 - Brown LM
Brown LM, Swanson CA, Gridley G, Swanson GM, Silverman DT, Greenberg RS, et al. Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States. Cancer Causes Control 1998;9:467-74.
 
27 - Castellsague X
Castellsague X, Munoz N, Stefani E de, Victora CG, Castelletto R, Rolon PA. Influence of mate drinking, hot beverages and diet on oesophageal cancer risk in South America. Int J Cancer 2000;88:658-64.
 
28 - Sharp L
Sharp L, Chilvers CE, Cheng KK, McKinney PA, Logan RF, Cook-Mozaffari P, et al. Risk factors for squamous cell carcinoma of the oesophagus in women: a case-control study. Br J Cancer 2001;85:1667-70.
 
29 - Cheng KK
Cheng KK, Day NE, Duffy SW, Lam TH, Fok M, Wong J. Pickled vegetables in the aetiology of oesophageal cancer in Hong Kong Chinese. Lancet 1992;339:1314-8.
 
30 - Lagergren J
Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-90 .
 
31 - Vaughan TL
Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the eso- phagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995;4:85-92.
 
32 - Brucher BL
Brucher BL, Stein HJ, Bartels H, Feussner H, Siewert JR. Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg 2001;25:745-9.
 
33 - Dunaway PM
Dunaway PM, Wong RK. Risk and surveillance intervals for squamous cell carcinoma in achalasia. Gastrointest Endosc Clin N Am 2001;11:425-34,ix.
 
34 - Sandler RS
Sandler RS, Nyren O, Ekbom A, Eisen GM, Yuen J, Josefsson S. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA 1995;274:1359-62.
 
35 - Ahsan H
Ahsan H, Neugut AI. Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med 1998;128:114-7.
 
36 - Ellis A
Ellis A, Field JK, Field EA, Friedmann PS, Fryer A, Howard P, et al. Tylosis associated with carcinoma of the oeso- phagus and oral leukoplakia in a large Liverpool family – a review of six generations. Eur J Cancer B Oral Oncol 1994;30B:102-12.
 
37 - Marger RS
Marger RS, Marger D. Carcinoma of the esophagus and tylosis. A lethal genetic combination. Cancer 1993;72:17-9.
 
38 - Kok TC
Kok TC, Nooter K, Tjong AHS, Smits HL, Schegget JT ter. No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Rotterdam Oesophageal Tumour Study Group. Eur J Cancer 1997;33:1865-8 .
 
39 - Shen ZY
Shen ZY, Hu SP, Lu LC, Tang CZ, Kuang ZS, Zhong SP, et al. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002;68:412-6.
 
40 - Syrjanen KJ
Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002;55:721-8.
 
41 - Shaheen NJ
Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 2000;119:333-8.
 
42 - Iftikhar SY
Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M. Length of Barrett’s oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155-8.
 
43 - Lagergren J
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
 
44 - Adang RP
Adang RP, Vismans JF, Talmon JL, Hasman A, Ambergen AW, Stockbrugger RW. Appropriateness of indications for diagnostic upper gastrointestinal endoscopy: association with relevant endoscopic disease. Gastrointest Endosc 1995;42:390-7.
 
45 - Canga C
Canga C, III, Vakil N. Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy. Am J Gastroenterol 2002;97:600-3.
 
46 - Gillen D
Gillen D, McColl KE. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55? Am J Gastroenterol 1999;94:75-9.
 
47 - Meineche-Schmidt V
Meineche-Schmidt V, Jorgensen T. ‘Alarm symptoms’ in patients with dyspepsia: a three-year prospective study from general practice. Scand J Gastroenterol 2002;37:999-1007 .
 
48 - Melleney E-MA
Melleney E-MA, Willoughby CP. Audit of a nurse endoscopist based one stop dyspepsia clinic. Postgrad Med J 2002;78:161-4.
 
49 - Numans ME
Numans ME, Graaf Y van der, Wit NJ de, Melker RA de. How useful is selection based on alarm symptoms in requesting gastroscopy? An evaluation of diagnostic determinants for gastro-oesophageal malignancy. Scand J Gastroenterol 2001;36:437-43.
 
50 - Sung JJ
Sung JJ, Lao WC, Lai MS, Li TH, Chan FK, Wu JC, et al. Incidence of gastroesophageal malignancy in patients with dyspepsia in Hong Kong: implications for screening strategies. Gastrointest Endosc 2001;54:454-8.
 
51 - Wallace MB
Wallace MB, Durkalski VL, Vaughan J, Palesch YY, Libby ED, Jowell PS, et al. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut 2001;49:29-34.
 
52 - Dores GM
Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, et al. Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3484-94.
 
53 - Leeuwen FE van
Leeuwen FE van, Klokman WJ, Veer MB, Hagenbeek A, Krol AD, Vetter UA, et al. Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood [see comments]. J Clin Oncol 2000;18:487-97.
 
54 - Wit NJ de
Wit NJ de, Folmer H, Barneveld TA van, et al. Multidisciplinaire richtlijn Maagklachten. Alphen a/d Rijn: Van Zuiden Communications BV, 2004.
 
55 - Numans ME
Numans ME, Wit NJ de, Dirven JAM, Hurenkamp GJB, Meijer QCM, Muris WM et al. NHG-Standaard Maagklachten. Huisarts Wet 2003;46(12):690-700.
 
56 - Alexander JA
Alexander JA, Jones SM, Smith CJ, Doull JA, Gietzen TH, Rathgaber SW. Usefulness of cytopathology and histology in the evaluation of Barrett’s esophagus in a community hospital. Gastrointest Endosc 1997;46:318-20.
 
57 - Geisinger KR
Geisinger KR. Endoscopic biopsies and cytologic brushings of the esophagus are diagnostically complementary. Am J Clin Pathol 1995;103:295-9.
 
58 - Roth MJ
Roth MJ, Liu SF, Dawsey SM, Zhou B, Copeland C, Wang GQ, et al. Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer 1997;80:2047-59.
 
59 - Stockeld D
Stockeld D, Ingelman-Sundberg H, Granstrom L, Fagerberg J, Backman L. Serial fine needle cytology in the diagnosis of esophageal cancer. Acta Cytol 2002;46:527-34.
 
60 - Lal N
Lal N, Bhasin DK, Malik AK, Gupta NM, Singh K, Mehta SK. Optimal number of biopsy specimens in the diagnosis of carcinoma of the oesophagus. Gut 1992;33:724-6.
 
61 - Hamilton SR
Hamilton SR, Aaltonen LA. WHO classification of tumours, Pathology and Genetics, Tumours of the digestive system. 2000.
 
62 - Sobin LH
Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. 2002.
 
63 - Kato H
Kato H, Igaki H, Tachimori Y, Watanabe H, Tsubosa Y, Nakanishi Y. Assessment of cervical lymph node metastasis in the staging of thoracic esophageal carcinoma. J Surg Oncol 2000;74:282-5.
 
64 - Nishimaki T
Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Hatakeyama K, Muto T. Patterns of lymphatic spread in thoracic eso- phageal cancer. Cancer 1994;74:4-11.
 
65 - Siewert JR
Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85:1457-9.
 
66 - Paraf F
Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F. Surgical pathology of adenocarcinoma arising in Barrett’s esophagus. Analysis of 67 cases. Am J Surg Pathol 1995;19:183-91.
 
67 - Robey-Cafferty SS
Robey-Cafferty SS, Naggar AK el, Sahin AA, Bruner JM, Ro JY, Cleary KR. Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. Am J Clin Pathol 1991;95:844-9.
 
68 - Sagar PM
Sagar PM, Johnston D, McMahon MJ, Dixon MF, Quirke P. Significance of circumferential resection margin involve- ment after oesophagectomy for cancer. Br J Surg 1993;80:1386-8.
 
69 - Eloubeidi MA
Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.Cancer 2002;95:1434-43.
 
70 - Kawahara K
Kawahara K, Maekawa T, Okabayashi K, Shiraishi T, Yoshinaga Y, Yoneda S, et al. The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol 1998;67:160-3.
 
71 - Korst RJ
Korst RJ, Rusch VW, Venkatraman E, Bains MS, Burt ME, Downey RJ, et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998;115:660 -9.
 
72 - Roder JD
Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-3.
 
73 - Tachibana M
Tachibana M, Dhar DK, Kinugasa S, Kotoh T, Shibakita M, Ohno S, et al. Esophageal cancer with distant lymph node metastasis: prognostic significance of metastatic lymph node ratio.J Clin Gastroenterol 2000;31:318-22.
 
74 - Tachibana M
Tachibana M, Yoshimura H, Kinugasa S, Dhar DK, Shibakita M, Ohno S, et al. Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer.Dig Liver Dis 2001;33:534-8.
 
75 - Glickman JN
Glickman JN, Torres C, Wang HH, Turner JR, Shahsafaei A, Richards WG, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;85:769-78.
 
76 - Izbicki JR
Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188-94.
 
77 - Komukai S
Komukai S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K. Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma. Br J Surg 2002;89:213-9.
 
78 - Nakamura T
Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Takasaki K. Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol 2002;79:224-9.
 
79 - Natsugoe S
Natsugoe S, Mueller J, Stein HJ, Feith M, Hofier H, Siewert JR. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer 1998;83:858-66.
 
80 - Sato F
Sato F, Shimada Y, Li Z, Watanabe G, Maeda M, Imamura M. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 2001;88:426-32.
 
81 - Boyce GA
Boyce GA. Endoscopic evaluation of the patient with esophageal carcinoma. Chest Surg Clin N Am 1994;4:257-68.
 
82 - Dooley CP
Dooley CP, Larson AW, Stace NH, Renner IG, Valenzuela JE, Eliasoph J, et al. Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study. Ann Intern Med 1984;101:538-45.
 
83 - Whyte RI
Whyte RI. Advances in the staging of intrathoracic malignancies. World J Surg 2001;25:167-73.
 
84 - Eloubeidi MA
Eloubeidi MA, Wallace MB, Reed CE, Hadzijahic N, Lewin DN, Velse A van, et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience. Gastrointest Endosc 2001;54:714-9.
 
85 - Reed CE
Reed CE, Mishra G, Sahai AV, Hoffman BJ, Hawes RH. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 1999;67:319-21 .
 
86 - Fockens P
Fockens P, Brande JH van den, Dullemen HM van, Lanschot JJ van, Tytgat GN. Endosonographic T-staging of esophageal carcinoma: a learning curve. Gastrointest Endosc 1996;44:58-62.
 
87 - Rasanen JV
Rasanen JV, Sihvo EI, Knuuti MJ, Minn HR, Luostarinen ME, Laippala P, et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarci- noma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003;10:954-60.
 
88 - Romagnuolo J
Romagnuolo J, Scott J, Hawes RH, Hoffman BJ, Reed CE, Aithal GP, et al. Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc 2002;55:648-54.
 
89 - Wallace MB
Wallace MB, Nietert PJ, Earle C, Krasna MJ, Hawes RH, Hoffman BJ, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 2002;74:1026-32.
 
90 - Wakelin SJ
Wakelin SJ, Deans C, Crofts TJ, Allan PL, Plevris JN, Paterson-Brown S. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol 2002;41:161-7.
 
91 - Botet JF
Botet JF, Lightdale CJ, Zauber AG, Gerdes H, Urmacher C, Brennan MF. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 1991;181:419-25.
 
92 - Dittler HJ
Dittler HJ, Siewert JR. Role of endoscopic ultrasonography in esophageal carcinoma. Endoscopy 1993;25:156-61.
 
93 - Catalano MF
Catalano MF, Dam J van, Sivak MV Jr. Malignant esophageal strictures: staging accuracy of endoscopic ultrasonography. Gastrointest Endosc 1995;41:535-9.
 
94 - Chak A
Chak A, Canto MI, Cooper GS, Isenberg G, Willis J, Levitan N, et al. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 2000;88:1788-95.
 
95 - Giovannini M
Giovannini M, Monges G, Seitz JF, Moutardier V, Bernardini D, Thomas P, et al. Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsy. Endoscopy 1999;31:536-40.
 
96 - Gress FG
Gress FG, Hawes RH, Savides TJ, Ikenberry SO, Lehman GA. Endoscopic ultrasound-guided fine-needle aspiration biopsy using linear array and radial scanning endosonography. Gastrointest Endosc 1997;45:243-50.
 
97 - Hiele M
Hiele M, Leyn P de, Schurmans P, Lerut A, Huys S, Geboes K, et al. Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction. Gastrointest Endosc 1997;45:381-6.
 
98 - Vilgrain V
Vilgrain V, Mompoint D, Palazzo L, Menu Y, Gayet B, Ollier P, et al. Staging of esophageal carcinoma: comparison of results with endoscopic sonography and CT. Am J Roentgenol 1990;155:277-81.
 
99 - Yoshikane H
Yoshikane H, Tsukamoto Y, Niwa Y, Goto H, Hase S, Shimodaira M, et al. Superficial esophageal carcinoma: evaluation by endoscopic ultrasonography. Am J Gastroenterol 1994;89:702-7 .
 
100 - Tio TL
Tio TL, Coene PP, Schouwink MH, Tytgat GN. Esophagogastric carcinoma: preoperative TNM classification with endosonography. Radiology 1989;173:411-7.
 
101 - Chak A
Chak A, Canto M, Gerdes H, Lightdale CJ, Hawes RH, Wiersema MJ, et al. Prognosis of esophageal cancers preopera- tively staged to be locally invasive (T4) by endoscopic ultrasound (EUS): a multicenter retrospective cohort study. Gastrointest Endosc 1995;42:501-6.
 
102 - Grimm H
Grimm H, Binmoeller KF, Hamper K, Koch J, Henne-Bruns D, Soehendra N. Endosonography for preoperative locoregional staging of esophageal and gastric cancer. Endoscopy 1993;25:224-30.
 
103 - Mallery S
Mallery S, Dam J van. EUS in the evaluation of esophageal carcinoma. Gastrointest Endosc 2000;52(suppl):S6-11.
 
104 - Vazquez-Sequeiros E
Vazquez-Sequeiros E, Norton ID, Clain JE, Wang KK, Affi A, Allen M, et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 2001;53:751-7.
 
105 - Vickers J
Vickers J, Alderson D. Oesophageal cancer staging using endoscopic ultrasonography. Br J Surg 1998;85:994-8.
 
106 - Lightdale CJ
Lightdale CJ. Staging of esophageal cancer. I: Endoscopic ultrasonography. Semin Oncol 1994;21:438-46.
 
107 - Rice TW
Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 2000;10:471-85.
 
108 - Heidemann J
Heidemann J, Schilling MK, Schmassmann A, Maurer CA, Buchler MW. Accuracy of endoscopic ultrasonography in preoperative staging of esophageal carcinoma. Dig Surg 2000; Digestive-Surgery 2000;17:3-224.
 
109 - Catalano MF
Catalano MF, Sivak MV Jr, Rice T, Gragg LA, Dam J van. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994;40:442-6.
 
110 - Fockens P
Fockens P, Kisman K, Merkus MP, Lanschot JJ van, Obertop H, Tytgat GN. The prognosis of esophageal carcinoma staged irresectable (T4) by endosonography. J Am Coll Surg 1998;186:17-23.
 
111 - Pfau PR
Pfau PR, Ginsberg GG, Lew RJ, Faigel DO, Smith DB, Kochman ML. Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol 2000;95:2813-5.
 
112 - Dam J van
Dam J van, Rice TW, Catalano MF, Kirby T, Sivak MV Jr. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 1993;71:2910-7.
 
113 - Wallace MB
Wallace MB, Hawes RH, Sahai AV, Velse A van, Hoffman BJ. Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management. Gastrointest Endosc 2000;51:309-13.
 
114 - Binmoeller KF
Binmoeller KF, Seifert H, Seitz U, Izbicki JR, Kida M, Soehendra N. Ultrasonic esophagoprobe for TNM staging of highly stenosing esophageal carcinoma. Gastrointest Endosc 1995;41:547-52.
 
115 - Bowrey DJ
Bowrey DJ, Clark GW, Roberts SA, Maughan TS, Hawthorne AB, Williams GT, et al. Endosonographic staging of 100 consecutive patients with esophageal carcinoma: introduction of the 8-mm esophagoprobe. Dis Esophagus 1999;12:258-63.
 
116 - Hawes RH
Hawes RH. Indications for EUS-directed FNA. Endoscopy 1998;30(suppl 1):A155-7.
 
117 - Wiersema MJ
Wiersema MJ, Vilmann P, Giovannini M, Chang KJ, Wiersema LM. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997;112:1087-95.
 
118 - Williams DB
Williams DB, Sahai AV, Aabakken L, Penman ID, Velse A van, Webb J, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999;44:720-6.
 
119 - Lightdale CJ
Lightdale CJ, Botet JF, Kelsen DP, Turnbull AD, Brennan MF. Diagnosis of recurrent upper gastrointestinal cancer at the surgical anastomosis by endoscopic ultrasound. Gastrointest Endosc 1989;35:407-12.
 
120 - Noh HM
Noh HM, Fishman EK, Forastiere AA, Bliss DF, Calhoun PS. CT of the esophagus: spectrum of disease with emphasis on esophageal carcinoma. Radiographics 1995;15:1113-34 .
 
121 - Izbicki JR
Izbicki JR, Hosch SB. Minimal dissemination of solid epithelial tumours: impact on staging and therapeutic strategy. Br J Surg 1997;84:897-8.
 
122 - Keene SA
Keene SA, Demeure MJ. The clinical significance of micrometastases and molecular metastases. Surgery 2001;129:1-5.
 
123 - Saunders HS
Saunders HS, Wolfman NT, Ott DJ. Esophageal cancer. Radiologic staging.Radiol Clin North Am 1997;35:281-94.
 
124 - Kumbasar B
Kumbasar B. Carcinoma of esophagus: radiologic diagnosis and staging. Eur J Radiol 2002;42:170-80.
 
125 - Flanagan FL
Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Sundaresan SR, Patterson GA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 1997;168:417-24.
 
126 - Fukunaga T
Fukunaga T, Okazumi S, Koide Y, Isono K, Imazeki K. Evaluation of esophageal cancers using fluorine-18-fluorodeoxy-glucose PET. J Nucl Med 1998;39:1002-7.
 
127 - Pham KH
Pham KH, Ramaswamy MR, Hawkins RA. Advances in positron emission tomography imaging for the GI tract. Gastrointest Endosc 2002;55(7 suppl):S53-63.
 
128 - Skehan SJ
Skehan SJ, Brown AL, Thompson M, Young JE, Coates G, Nahmias C. Imaging features of primary and recurrent esophageal cancer at FDG PET. Radiographics 2000;20:713-23.
 
129 - Luketich JD
Luketich JD, Schauer PR, Meltzer CC, Landreneau RJ, Urso GK, Townsend DW, et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997;64:765-9.
 
130 - Yoon YC
Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 2003;227:764-70.
 
131 - Luketich JD
Luketich JD, Friedman DM, Weigel TL, Meehan MA, Keenan RJ, Townsend DW, et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 1999;68:1133-6.
 
132 - Flamen P
Flamen P, Lerut A, Cutsem E van, Cambier JP, Maes A, Wever W de, et al. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 2000;120:1085-92.
 
133 - Doldi SB
Doldi SB, Lattuada E, Zappa MA, Cioffi U, Pieri G, Massari M, et al. Ultrasonographic evaluation of the cervical lymph nodes in preoperative staging of esophageal neoplasms. Abdom Imaging 1998;23:275-7.
 
134 - Bonvalot S
Bonvalot S, Bouvard N, Lothaire P, Maurel J, Galateau F, Segol P, et al. Contribution of cervical ultrasound and ultrasound fine-needle aspiration biopsy to the staging of thoracic oesophageal carcinoma. Eur J Cancer 1996;32A:893-5.
 
135 - Griffith JF
Griffith JF, Chan AC, Ahuja AT, Leung SF, Chow LT, Chung SC, et al. Neck ultrasound in staging squamous oesophageal carcin. Clin Radiol 2000;55:696-701 .
 
136 - Natsugoe S
Natsugoe S, Yoshinaka H, Shimada M, Shirao K, Nakano S, Kusano C, et al. Assessment of cervical lymph node metastasis in esophageal carcinoma using ultrasonography. Ann Surg 1999;229:62-6.
 
137 - Overhagen H van
Overhagen H van, Lameris JS, Berger MY, Klooswijk AI, Tilanus HW, Pel R van, et al. CT assessment of resectability prior to transhiatal esophagectomy for esophageal/gastroesophageal junction carcinoma. J Comput Assist Tomogr 1993;17:367-73.
 
138 - Giovagnoni A
Giovagnoni A, Valeri G, Ferrara C. MRI of esophageal cancer. Abdom Imaging 2002;27:361-6.
 
139 - Takashima S
Takashima S, Takeuchi N, Shiozaki H, Kobayashi K, Morimoto S, Ikezoe J, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. Am J Roentgenol 1991;156:297-302.
 
140 - Thompson WM
Thompson WM, Halvorsen RA Jr. Staging esophageal carcinoma II: CT and MRI. Semin Oncol 1994;21:447-52.
 
141 - Hoed RD van den
Hoed RD van den, Feldberg MA, Leeuwen MS van, Dalen T van, Obertop H, Kooyman CD, et al. CT prediction of irresectability in esophageal carcinoma: value of additional patient positions and relation to patient outcome. Abdom Imaging 1997;22:132-7.
 
142 - Wu LF
Wu LF, Wang BZ, Feng JL, Cheng WR, Liu GR, Xu XH, et al. Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI. World J Gastroenterol 2003;9:219-24.
 
143 - Baisi A
Baisi A, Bonavina L, Peracchia A. Bronchoscopic staging of squamous cell carcinoma of the upper thoracic esophagus. Arch Surg 1999;134:140-3.
 
144 - Choi TK
Choi TK, Siu KF, Lam KH, Wong J. Bronchoscopy and carcinoma of the esophagus I. Findings of bronchoscopy in carcinoma of the esophagus. Am J Surg 1984;147:757-9 .
 
145 - Riedel M
Riedel M, Hauck RW, Stein HJ, Mounyam L, Schulz C, Schomig A, et al. Preoperative bronchoscopic assessment of airway invasion by esophageal cancer: a prospective study. Chest 1998;113:687-95.
 
146 - Nishimura Y
Nishimura Y, Osugi H, Inoue K, Takada N, Takamura M, Kinosita H. Bronchoscopic ultrasonography in the diagnosis of tracheobronchial invasion of esophageal cancer. J Ultrasound Med 2002;21:49-58.
 
147 - Westreenen HL van
Westreenen HL van, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, Lanschot JJ van, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.J Clin Oncol 2004;22:3805-12.
 
148 - Liberale G
Liberale G, Laethem JL van, Gay F, Goldman S, Nagy N, Coppens E, et al. The role of PET scan in the preoperative management of oesophageal cancer. Eur J Surg Oncol 2004;30:942-7 .
 
149 - Heeren PA
Heeren PA, Jager PL, Bongaerts F, Dullemen H van, Sluiter W, Plukker JT. Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med 2004;45:980-7.
 
150 - Block MI
Block MI, Patterson GA, Sundaresan RS, Bailey MS, Flanagan FL, Dehdashti F, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997;64:770-6.
 
151 - Kole AC
Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastro- esophageal malignancy. Br J Cancer 1998;78:521-7 .
 
152 - Rankin SC
Rankin SC, Taylor H, Cook GJ, Mason R. Computed tomography and positron emission tomography in the pre- operative staging of oesophageal carcinoma. Clin Radiol 1998;53:659-65 .
 
153 - Kobori O
Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999;86:1638-48 .
 
154 - Kato H
Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002;94:921-8.
 
155 - Choi JY
Choi JY, Lee KH, Shim YM, Lee KS, Kim JJ, Kim SE, et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 2000;41:808-15.
 
156 - Junginger T
Junginger T, Kneist W, Schreckenberger M, Menzel C, Oberholzer K, Bartenstein P. Positronen-Emissions- Tomographie zum präoperativen Staging des Ösophaguskarzinoms. Dtsch Med Wochenschr 2002;127:1935-41.
 
157 - Wren SM
Wren SM, Stijns P, Srinivas S. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 2002;137:1001-6.
 
158 - Meltzer CC
Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, et al. Whole-body FDG positron emis- sion tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 2000;25:882-7 .
 
159 - Flamen P
Flamen P, Lerut A, Cutsem E van, Wever W de, Peeters M, Stroobants S, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-10.
 
160 - Jager PL
Jager PL, Que TH, Vaalburg W, Pruim J, Elsinga P, Plukker JT. Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med 2001;28:1845-9.
 
161 - Yoon YC
Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with eso- phageal sqaumous cell carcinoma: CT versus FDG PET for presurgical detection-prospective study. Radiology 2003;227:764-70.
 
162 - Krasna MJ
Krasna MJ, Reed CE, Jaklitsch MT, Cushing D, Sugarbaker DJ. Thoracoscopic staging of esophageal cancer: a prospetive, multiinstitutional trial. Cancer and Leukemia Group B Thoracic Surgeons. Ann Thorac Surg 1995;60:1337-40.
 
163 - Krasna MJ
Krasna MJ, Jiao X, Sonett JR, Gamliel Z, Eslami A, Raefaly Y, et al. Thoracoscopic and laparoscopic lymph node staging in esophageal cancer: do clinicopathological factors affect the outcome?Ann Thorac Surg 2002;73:1710-3.
 
164 - Whyte RI
Whyte RI. Advances in the staging of intrathoracic malignancies. World J Surg 2001;25:167-73.
 
165 - Nguyen NT
Nguyen NT, Roberts PF, Follette DM, Lau D, Lee J, Urayama S, et al. Evaluation of minimally invasive surgical staging for esophageal cancer. Am J Surg 2001;182:702-6.
 
166 - O’Brien MG
O’Brien MG, Fitzgerald EF, Lee G, Crowley M, Shanahan F, O’Sullivan GC. A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. Am J Gastroenterol 1995;90:2191-4 .
 
167 - Hunerbein M
Hunerbein M, Rau B, Schlag PM. Laparoscopy and laparoscopic ultrasound for staging of upper gastrointestinal tumours. Eur J Surg Oncol 1995;21:50-5.
 
168 - Mortensen MB
Mortensen MB, Scheel-Hincke JD, Madsen MR, Qvist N, Hovendal C. Combined endoscopic ultrasonography and laparoscopic ultrasonography in the pretherapeutic assessment of resectability in patients with upper gastrointestinal malignancies. Scand J Gastroenterol 1996;31:1115-9.
 
169 - Dijkum EJ van
Dijkum EJ van, Wit LT de, Delden OM van, Kruyt PM, Lanschot JJ van, Rauws EA, et al. Staging laparoscopy and laparoscopic ultrasonography in more than 400 patients with upper gastrointestinal carcinoma. J Am Coll Surg 1999;189:459-65 .
 
170 - Wakelin SJ
Wakelin SJ, Deans C, Crofts TJ, Allan PL, Plevris JN, Paterson-Brown S. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol 2002;41:161-7 .
 
171 - Bemelman WA
Bemelman WA, Delden OM van, Lanschot JJ van, Wit LT de, Smits NJ, Fockens P, et al. Laparoscopy and laparoscopic ultrasonography in staging of carcinoma of the esophagus and gastric cardia. J Am Coll Surg 1995;181:421-5.
 
172 - Romijn MG
Romijn MG, Overhagen H van, Spillenaar Bilgen EJ, IJzermans JN, Tilanus HW, Lameris JS. Laparoscopy and laparoscopic ultrasonography in staging of oesophageal and cardial carcinoma. Br J Surg 1998;85:1010-2.
 
173 - Smith A
Smith A, Finch MD, John TG, Garden OJ, Brown SP. Role of laparoscopic ultrasonography in the management of patients with oesophagogastric cancer. Br J Surg 1999;86:1083-7 .
 
174 - Luketich JD
Luketich JD, Schauer P, Landreneau R, Nguyen N, Urso K, Ferson P, et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 1997;114:817-21 .
 
175 - Schlemper RJ
Schlemper RJ, Dawsey SM, Itabashi M, Iwashita A, Kato Y, Koike M, et al. Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer 2000;88:996-1006 .
 
176 - Schlemper RJ
Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastro- intestinal epithelial neoplasia. Gut 2000;47:251-5.
 
177 - Buttar NS
Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001;120:1630-9.
 
178 - Weston AP
Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A. Long-term follow-up of Barrett’s high-grade dysplasia. Am J Gastroenterol 2000;95:1888-93.
 
179 - Bouquot JE
Bouquot JE, Gnepp DR. Laryngeal precancer: a review of the literature, commentary, and comparison with oral leukoplakia. Head Neck 1991;13:488-97.
 
180 - Crissman JD
Crissman JD, Zarbo RJ. Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract. Am J Surg Pathol 1989;13(suppl 1):5-16.
 
181 - Montgomery E
Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001;32:379-88 .
 
182 - Skacel M
Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am J Gastroenterol 2000;95:3383-7.
 
183 - Hulscher JB
Hulscher JB, Haringsma J, Benraadt J, Offerhaus GJ, Kate FJ ten, Baak JP, et al. Comprehensive Cancer Centre Amsterdam Barrett Advisory Committee: first results. Neth J Med 2001;58:3-8.
 
184 - Dawsey SM
Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998;83:220-31.
 
185 - Canto MI
Canto MI, Setrakian S, Willis JE, Chak A, Petras RE, Sivak MV. Methylene blue staining of dysplastic and nondysplastic Barrett’s esophagus: an in vivo and ex vivo study. Endoscopy 2001;33:391-400.
 
186 - Dave U
Dave U, Shousha S, Westaby D. Methylene blue staining: is it really useful in Barrett’s esophagus? Gastrointest Endosc 2001;53:333-5.
 
187 - Endo T
Endo T, Awakawa T, Takahashi H, Arimura Y, Itoh F, Yamashita K, et al. Classification of Barrett’s epithelium by magnifying endoscopy. Gastrointest Endosc 2002;55:641-7 .
 
188 - Guelrud M
Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett’s esophagus. Gastrointest Endosc 2001;53:559-65.
 
189 - Sharma P
Sharma P, Weston AP, Topalovski M, Cherian R, Bhattacharyya A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus. Gut 2003;52:24-7.
 
190 - Reid BJ
Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol 2000;95:3089-96 .
 
191 - Bergman JJ
Bergman JJ, Fockens P. Endoscopic ultrasonography in patients with gastro-esophageal cancer. Eur J Ultrasound 1999;10:127-38.
 
192 - Scotiniotis IA
Scotiniotis IA, Kochman ML, Lewis JD, Furth EE, Rosato EF, Ginsberg GG. Accuracy of EUS in the evaluation of Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc 2001;54:689-96.
 
193 - Hasegawa N
Hasegawa N, Niwa Y, Arisawa T, Hase S, Goto H, Hayakawa T. Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonography. Gastrointest Endosc 1996;44:388-93.
 
194 - Natsugoe S
Natsugoe S, Yoshinaka H, Morinaga T, Shimada M, Baba M, Fukumoto T, et al. Ultrasonographic detection of lymph-node metastases in superficial carcinoma of the esophagus. Endoscopy 1996;28:674-9.
 
195 - Shimizu Y
Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper.Gastrointest Endosc 2002;56:387-90.
 
196 - Endo M
Endo M, Kawano T. Detection and classification of early squamous cell esophageal cancer. Dis Esophagus 1997;10:155-8.
 
197 - Fujita H
Fujita H, Sueyoshi S, Yamana H, Shinozaki K, Toh U, Tanaka Y, et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 2001;25:424-31.
 
198 - Inoue H
Inoue H, Tani M, Nagai K, Kawano T, Takeshita K, Endo M, et al. Treatment of esophageal and gastric tumors. Endoscopy 1999;31:47-55.
 
199 - Katada C
Katada C, Muto M, Manabe T, Boku N, Ohtsu A, Yoshida S. Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 2003;57:165-9.
 
200 - Kodama M
Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998;123:432-9.
 
201 - Narahara H
Narahara H, Iishi H, Tatsuta M, Uedo N, Sakai N, Yano H, et al. Effectiveness of endoscopic mucosal resection with submucosal saline injection technique for superficial squamous carcinomas of the esophagus. Gastrointest Endosc 2000;52:730-4.
 
202 - Nijhawan PK
Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus. Gastrointest Endosc 2000;52:328-32.
 
203 - Yoshinaka H
Yoshinaka H, Shimazu H, Fukumoto T, Baba M. Superficial esophageal carcinoma: a clinicopathological review of 59 cases.Am J Gastroenterol 1991;86:1413-8.
 
204 - Schnell TG
Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O’Connell S, et al. Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Gastroenterology 2001;120:1607-19.
 
205 - Buttar NS
Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus. Gastrointest Endosc 2001;54:682-8.
 
206 - May A
May A, Gossner L, Pech O, Fritz A, Gunter E, Mayer G, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14:1085-91.
 
207 - Ell C
Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 2000;118:670-7 .
 
208 - Overholt BF
Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc 1999;49:1-7.
 
209 - Overholt BF
Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results.Gastrointest Endosc 2003;58:183-8 .
 
210 - Ackroyd R
Ackroyd R, Brown NJ, Davis MF, Stephenson TJ, Stoddard CJ, Reed MW. Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett’s esophagus. Dis Esophagus 2000;13:18-22.
 
211 - Gossner L
Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-55.
 
212 - Hage M
Hage M, Siersema PD, Dekken H van, Steyerberg EW, Haringsma J, et al. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial. Gut 2004;53:785-90.
 
213 - Araki K
Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002;94:570-5.
 
214 - Bonavina L
Bonavina L, Ruol A, Ancona E, Peracchia A. Prognosis of early squamous cell carcinoma of the esophagus after surgical therapy. Dis Esophagus 1997;10:162-4.
 
215 - Matsubara T
Matsubara T, Ueda M, Abe T, Akimori T, Kokudo N, Takahashi T. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus. Br J Surg 1999;86:669-73.
 
216 - Nabeya K
Nabeya K, Hanaoka T, Li S, Nyumura T. What is the ideal treatment for early esophageal cancer? Endoscopy 1993;25:670-1.
 
217 - Nagawa H
Nagawa H, Kaizaki S, Seto Y, Tominaga O, Muto T. The relationship of macroscopic shape of superficial esophageal carcinoma to depth of invasion and regional lymph node metastasis. Cancer 1995;75:1061-4.
 
218 - Nakajima Y
Nakajima Y, Nagai K, Miyake S, Ohashi K, Kawano T, Iwai T. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn J Cancer Res 2002;93:305-12.
 
219 - Nishimaki T
Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Watanabe H, Muto T. Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment. World J Surg 1993;17:766-71.
 
220 - Tachibana M
Tachibana M, Yoshimura H, Kinugasa S, Hashimoto N, Dhar DK, Abe S, et al. Clinicopathological features of superficial squamous cell carcinoma of the esophagus. Am J Surg 1997;174:49-53.
 
221 - Tajima Y
Tajima Y, Nakanishi Y, Ochiai A, Tachimori Y, Kato H, Watanabe H, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 2000;88:1285-93 .
 
222 - Fernando HC
Fernando HC, Luketich JD, Buenaventura PO, Perry Y, Christie NA. Outcomes of minimally invasive esophagectomy (MIE) for high-grade dysplasia of the esophagus. Eur J Cardiothorac Surg 2002;22:1-6.
 
223 - Nigro JJ
Nigro JJ, Hagen JA, Meester TR de, Meester SR de, Peters JH, Oberg S, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 1999;117:16-23.
 
224 - Nigro JJ
Nigro JJ, Hagen JA, Meester TR de, Meester SR de, Theisen J, Peters JH, et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999;230:433-8.
 
225 - Peters JH
Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813-21.
 
226 - Rice TW
Rice TW, Blackstone EH, Goldblum JR, Camp MM de, Murthy SC, Falk GW, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg 2001; 122(6):1077-90 .
 
227 - Ruol A
Ruol A, Merigliano S, Baldan N, Santi S, Petrin GF, Bonavina L, et al. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett’s eso- phagus (type I) and early cancer of the cardia (type II). Dis Esophagus 1997;10:190-5.
 
228 - Stein HJ
Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 2000;232:733-42.
 
229 - Sandick JW van
Sandick JW van, Lanschot JJ van, Kate FJ ten, Offerhaus GJ, Fockens P, Tytgat GN, et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000;88:2429-37 .
 
230 - Ormsby AH
Ormsby AH, Petras RE, Henricks WH, Rice TW, Rybicki LA, Richter JE, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002;51 (5):671-6 .
 
231 - Hulscher JB
Hulscher JB, Tijssen JG, Obertop H, Lanschot JJ van. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001;72:306-13 .
 
232 - Leonard GD
Leonard GD, McCaffrey JA, Maher M. Optimal therapy for oesophageal cancer. Cancer Treat Rev 2003;29:275-82.
 
233 - Wu PC
Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4:481-8.
 
234 - Hulscher JB
Hulscher JB, Sandick JW van, Boer AG de, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
 
235 - Lanschot JJ van
Lanschot JJ van, Tilanus H, Obertop H. Surgical treatment of esophageal cancer [2] (multiple letters). N Engl J Med 2003;(0028-4793):1177-9.
 
236 - Lanschot JJB van
Lanschot JJB van, Tilanus HW, Obertop H. Transhiatal or transthoracic resection of oesophageal carcinoma based on tumour location, positive high-thoracic lymph nodes and preoperative physical condition. Ned Tijdschr Geneeskd 2003;147(43):2128-33.
 
237 - Sagar PM
Sagar PM, Johnston D, McMahon MJ, Dixon MF, Quirke P. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg 1993;80:1386-8.
 
238 - Urschel JD
Urschel JD, Urschel DM, Miller JD, Bennett WF, Young JE. A meta-analysis of randomized controlled trials of route of reconstruction after esophagectomy for cancer. Am J Surg 2001;182:470-5.
 
239 - Lanschot JJ van
Lanschot JJ van, Hop WC, Voormolen MH, Deelen RA van, Blomjous JG, Tilanus HW. Quality of palliation and possible benefit of extra-anatomic reconstruction in recurrent dysphagia after resection of carcinoma of the esophagus. J Am Coll Surg 1994;179:705-13.
 
240 - Roder JD
Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-3 .
 
241 - Akiyama H
Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic eso- phagus. Ann Surg 1994;220:364-72 .
 
242 - Nishihira T
Nishihira T, Hirayama K, Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998;175:47-51.
 
243 - Matsubara T
Matsubara T, Ueda M, Nagao N, Takahashi T, Nakajima T, Nishi M. Cervicothoracic approach for total mesoesophageal dissection in cancer of the thoracic esophagus. J Am Coll Surg 1998;187:238-45.
 
244 - Altorki N
Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-83.
 
245 - Urschel JD
Urschel JD. Does the interponat affect outcome after esophagectomy for cancer? Dis Esophagus 2001;2:124-30.
 
246 - Collard JM
Collard JM, Tinton N, Malaise J, Romagnoli R, Otte JB, Kestens PJ. Esophageal replacement: gastric tube or whole stomach? Ann Thorac Surg 1995;60:261-6.
 
247 - Chasseray VM
Chasseray VM, Kiroff GK, Buard JL, Launois B. Cervical or thoracic anastomosis for esophagectomy for carcinoma. Surg Gynecol Obstet 1989;169:55-62 .
 
248 - Ribet M
Ribet M, Debrueres B, Lecomte-Houcke M. Oesophagectomie pour cancer malpighien évolué de l’oesophage thoracique. Anastomose oeso-gastrique au cou ou dans le thorax? Résultats tardifs d’une étude prospective ‘ran- domisée. [Esophagectomy for advanced malpighian cancer of the thoracic esophagus. Esogastric anastomosis in the neck or in the thorax? Late results of a ‘randomized’ prospective study]. Ann Chir 1992;46:905-11.
 
249 - Goldminc M
Goldminc M, Maddern G, Prise E le, Meunier B, Campion JP, Launois B. Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 1993;80:367-70 .
 
250 - Chu KM
Chu KM, Law SY, Fok M, Wong J. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 1997;174:320-4.
 
251 - Bardini R
Bardini R, Asolati M, Ruol A, Bonavina L, Baseggio S, Peracchia A. Anastomosis. World J Surg 1994;18:373-8.
 
252 - Moorehead RJ
Moorehead RJ, Wong J. Gangrene in esophageal substitutes after resection and bypass procedures for carcinoma of the esophagus. Hepatogastroenterology 1990;37:364-7.
 
253 - Pierie JP
Pierie JP, Graaf PW de, Poen H, Tweel I van der, Obertop H. Incidence and management of benign anastomotic stricture after cervical oesophagogastrostomy. Br J Surg 1993;80:471-4 .
 
254 - Urschel JD
Urschel JD, Blewett CJ, Bennett WF, Miller JD, Young JE. Handsewn or stapled esophagogastric anastomoses after esophagectomy for cancer: meta-analysis of randomized controlled trials. Dis Esophagus 2001;14:212-7.
 
255 - Craig SR
Craig SR, Walker WS, Cameron EW, Wightman AJ. A prospective randomized study comparing stapled with handsewn oesophagogastric anastomoses. J R Coll Surg Edinb 1996;41:17-9.
 
256 - Valverde A
Valverde A, Hay JM, Fingerhut A, Elhadad A. Manual versus mechanical esophagogastric anastomosis after resection for carcinoma: a controlled trial. French Associations for Surgical Research. Surgery 1996;120:476-83.
 
257 - Law S
Law S, Fok M, Chu KM, Wong J. Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg 1997;226:169-73.
 
258 - Orringer MB
Orringer MB, Marshall B, Iannettoni MD. Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg 2000;119:277-88.
 
259 - Zieren HU
Zieren HU, Muller JM, Pichlmaier H. Prospective randomized study of one- or two-layer anastomosis following oesophageal resection and cervical oesophagogastrostomy. Br J Surg 1993;80:608-11.
 
260 - Bardini R
Bardini R, Bonavina L, Asolati M, Ruol A, Castoro C, Tiso E. Single-layered cervical esophageal anastomoses: a prospective study of two suturing techniques. Ann Thorac Surg 1994;58:1087-9.
 
261 - Muller JM
Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-57.
 
262 - Zieren HU
Zieren HU, Muller JM, Jacobi CA, Pichlmaier H. Soll beim Magenhochzug nach subtotaler Oesophagektomie mit oesophago-gastraler Anastomose am Hals eine Pyloroplastik durchgefuhrt werden? Eine prospektiv randomisierte Studie. [Should a pyloroplasty be carried out in stomach transposition after subtotal esophagectomy with esophago- gastric anastomosis at the neck? A prospective randomized study]. Chirurg 1995;66:319-25.
 
263 - Mannell A
Mannell A, McKnight A, Esser JD. Role of pyloroplasty in the retrosternal stomach: results of a prospective, randomized, controlled trial. Br J Surg 1990;77:57-9.
 
264 - Fok M
Fok M, Cheng SW, Wong J. Pyloroplasty versus no drainage in gastric replacement of the esophagus. Am J Surg 1991;162:447-52.
 
265 - Sauvanet A
Sauvanet A, Baltar J, Mee J le, Belghiti J. Diagnosis and conservative management of intrathoracic leakage after oesophagectomy. Br J Surg 1998;85:1446-9.
 
266 - Tanomkiat W
Tanomkiat W, Galassi W. Barium sulfate as contrast medium for evaluation of postoperative anastomotic leaks. Acta Radiol 2000;41:482-5 .
 
267 - Hulscher JB
Hulscher JB. Vocal cord paralysis after subtotal oesophagectomy. Br J Surg 1999;12:1583-7.
 
268 - Bonavina L
Bonavina L, Saino G, Bona D, Abraham M, Peracchia A. Thoracoscopic management of chylothorax complicating esophagectomy. J Laparoendosc Adv Surg Tech A 2001;11:367-9.
 
269 - Cope C
Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. J Vasc Interv Radiol 1998;9:727-34.
 
270 - Gier HH de
Gier HH de, Balm AJ, Bruning PF, Gregor RT, Hilgers FJ. Systematic approach to the treatment of chylous leakage after neck dissection. Head Neck 1996;18:347-51.
 
271 - Jensen GL
Jensen GL, Mascioli EA, Meyer LP, Lopes SM, Bell SJ, Babayan VK, et al. Dietary modification of chyle composition in chylothorax. Gastroenterology 1989;97:761-5 .
 
272 - Rubin JW
Rubin JW, Moore HV, Ellison RG. Chylothorax: therapeutic alternatives. Am Surg 1977;43:292-7.
 
273 - Wemyss-Holden SA
Wemyss-Holden SA, Launois B, Maddern GJ. Management of thoracic duct injuries after oesophagectomy. Br J Surg 2001;88:1442-8 .
 
274 - Bolger C
Bolger C, Walsh TN, Tanner WA, Keeling P, Hennessy TP. Chylothorax after oesophagectomy. Br J Surg 1991;78:587-8.
 
275 - Dougenis D
Dougenis D, Walker WS, Cameron EW, Walbaum PR. Management of chylothorax complicating extensive esophageal resection. Surg Gynecol Obstet 1992;174:501-6.
 
276 - Martin IC
Martin IC, Marinho LH, Brown AE, McRobbie D. Medium chain triglycerides in the management of chylous fistulae following neck dissection. Br J Oral Maxillofac Surg 1993;31:236-8.
 
277 - Dugue L
Dugue L, Sauvanet A, Farges O, Goharin A, Mee J le, Belghiti J. Output of chyle as an indicator of treatment for chylothorax complicating oesophagectomy. Br J Surg 1998;85:1147-9.
 
278 - Orringer MB
Orringer MB, Bluett M, Deeb GM. Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy. Surgery 1988;104:720-6.
 
279 - Honkoop P
Honkoop P, Siersema PD, Tilanus HW, Stassen LP, Hop WC, Blankenstein M van. Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg 1996;111:1141-6.
 
280 - Urschell JD
Urschell JD, Blewett CJ, Young JEM, Miller JD, Benett WF. Pyloric drainage (pyloroplasty) or no drainage in gastric reconstruction after esophagectomy: a meta-analysis of randomized controlled trials. Dig Surg 2002;19:160-4.
 
281 - Briel JW
Briel JW, Tamhankar AP, Hagen JA, Meester SR de, Johansson J, Choustoulakis E, et al. Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 2004;198:536-41; discussion 541-2.
 
282 - Marks RD Jr
Marks RD Jr, Scruggs HJ, Wallace KM. Preoperative radiation therapy for carcinoma of the esophagus. Cancer 1976;38:84-9.
 
283 - Nakayama K
Nakayama K, Kinoshita Y. Cancer of the gastrointestinal tract. II. Esophagus: Treatment – localized and advanced. Surgical treatment combined with preoperative concentrated irradiation. JAMA 1974;227:178-81.
 
284 - Parker EF
Parker EF, Gregorie HB. Carcinoma of the esophagus. Long-term results. JAMA 1976;235:1018-20.
 
285 - Lanschot JJ van
Lanschot JJ van, Tilanus H, Obertop H. Surgical treatment of esophageal cancer [2] (multiple letters). N Engl J Med 2003;(0028-4793):1177-9.
 
286 - Arnott SJ
Arnott SJ, Duncan W, Kerr GR, Walbaum PR, Cameron E, Jack WJ, et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 1992;24:108-13.
 
287 - Gignoux M
Gignoux M, Roussel A, Paillot B, Gillet M, Schlag P, Dalesio O, et al. The value of preoperative radiotherapy in esophageal cancer: results of a study by the EORTC. Recent Results Cancer Res 1988;110:1-13.
 
288 - Launois B
Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981;153:690-2.
 
289 - Nygaard K
Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-9.
 
290 - Wang M
Wang M, Gu XZ, Yin WB, Huang GJ, Wang LJ, Zhang DW. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 1989;16:325-7.
 
291 - Arnott SJ
Arnott SJ, Duncan W, Gignoux M, Girling DJ, Hansen HS, Launois B, et al. Preoperative radiotherapy for esophageal carcinoma. Oeosphageal Cancer Collaborative Group. Cochrane Database Syst Rev 2000;(2):CD001799.
 
292 - Kelsen DP
Kelsen DP, Ilson DH. Chemotherapy and combined-modality therapy for esophageal cancer. Chest 1995;107:6-232S.
 
293 - Hilgenberg AD
Hilgenberg AD, Carey RW, Wilkins EW Jr, Choi NC, Mathisen DJ, Grillo HC. Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 1988;45:357-63.
 
294 - Kok TC
Kok TC, Lanschot JJB van, Siersema PD, Overhagen H van, Tilanus HW. Neoadjuvant chemotherapy in operable squamous cell cancer of the esophagus: final report of a phase III multicenter randomised trial. Proc Am Soc Clin Oncol 1997;17. Abstract.
 
295 - Law S
Law S, Fok M, Chow S, Chu KM, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997;114:210-7.
 
296 - Roth JA
Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988;96:242-8.
 
297 - Schlag PM
Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg 1992;127:1446-50 .
 
298 - Maipang T
Maipang T, Vasinanukorn P, Petpichetchian C, Chamroonkul S, Geater A, Chansawwaang S, et al. Induction chemo- therapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994;56:191-7.
 
299 - Kelsen DP
Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-84.
 
300 - Ancona E
Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001;91:2165-74.
 
301 - Medical Research Council Oesophageal Cancer Working Group
Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-33.
 
302 - Malthaner R
Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2003(4):CD001556. Review.
 
303 - Urschel JD
Urschel JD. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002;3:274-9.
 
304 - Apinop C
Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepato- gastroenterology 1994;41:391-3.
 
305 - Bosset JF
Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-7.
 
306 - Prise E le
Prise E le, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-84.
 
307 - Urba SG
Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-13 .
 
308 - Walsh TN
Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
 
309 - Fok M
Fok M, Sham JS, Choy D, Cheng SW, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 1993;113:138-47 .
 
310 - Teniere P
Teniere P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 1991;173:123-30.
 
311 - Zieren HU
Zieren HU, Muller JM, Jacobi CA, Pichlmaier H, Muller RP, Staar S. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 1995;19:444-9.
 
312 - Xiao ZF
Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003;75:331-6 .
 
313 - Ando N
Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, Ide H, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997;114:205-9.
 
314 - Pouliquen X
Pouliquen X, Levard H, Hay JM, McGee K, Fingerhut A, Langlois-Zantin O. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research. Ann Surg 1996;223:127-33.
 
315 - Kelly S
Kelly S, Harris KM, Berry E, Hutton J, Roderick P, Cullingworth J, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma.Gut 2001;49:534-9.
 
316 - Fockens P
Fockens P, Kisman K, Merkus MP, Lanschot JJ van, Obertop H, Tytgat GN. The prognosis of esophageal carcinoma staged irresectable (T4) by endosonography. J Am Coll Surg 1998;186:17-23.
 
317 - Chak A
Chak A, Canto M, Gerdes H, Lightdale CJ, Hawes RH, Wiersema MJ, et al. Prognosis of esophageal cancers pre- operatively staged to be locally invasive (T4) by endoscopic ultrasound (EUS): a multicenter retrospective cohort study. Gastrointest Endosc 1995;42:501-6.
 
318 - Kaneko K
Kaneko K, Ito H, Konishi K, Kurahashi T, Ito T, Katagiri A, et al. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer 2003;88:18-24.
 
319 - Nishimura Y
Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H. Prospective trial of concurrent chemoradio- therapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 2002;53:134-9.
 
320 - Raemdonck D van
Raemdonck D van, Cutsem E van, Menten J, Ectors N, Coosemans W, Leyn P de, et al. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 1997;11:828-37.
 
321 - Andersen AP
Andersen AP, Berdal P, Edsmyr F, Hagen S, Hatlevoll R, Nygaard K, et al. Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer. Radiother Oncol 1984;2:179-88.
 
322 - Araujo CM
Araujo CM, Souhami L, Gil RA, Carvalho R, Garcia JA, Froimtchuk MJ, et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991;67:2258-61.
 
323 - Cooper JS
Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson J-AJ, Al Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
 
324 - Earle JD
Earle JD, Gelber RD, Moertel CG, Hahn RG. A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1980;6:821-6.
 
325 - Hatlevoll R
Hatlevoll R, Hagen S, Hansen HS, Hultborn R, Jakobsen A, Mantyla M, et al. Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective ran- domized multicentre study: the second Scandinavian trial in esophageal cancer. Radiother Oncol 1992;24:114-6.
 
326 - Hukku S
Hukku S, Fernandes P, Vasishta S, Sharma VK. Radiation therapy alone and in combination with bleomycin and 5-fluorouracil in advanced carcinoma esophagus. Indian J Cancer 1989;26:131-6 .
 
327 - Kaneta T
Kaneta T, Takai Y, Nemoto K, Kakuto Y, Ogawa Y, Ariga H, et al. [Effects of combination chemoradiotherapy with daily low-dose CDDP for esophageal cancer -- results of a randomized trial]. Gan To Kagaku Ryoho 1997;24:2099-104.
 
328 - Hishikawa Y
Hishikawa Y, Miura T, Oshitani T, Yoshimura H, Ono K, Takahashi M, et al. A randomized prospective study of adjuvant chemotherapy after radiotherapy in unresectable esophageal carcinoma. Dis Esophagus 1991;4:2-90.
 
329 - Kolaric K
Kolaric K, Zupanc D, Tometic Z, et al. Radiation alone vs radiation + chemotherapy (ddp + 5FU) in locoregional advanced esophageal cancer – Preliminary report of a prospective randomized study. Ann Oncol 1. 1990. Abstract.
 
330 - Lu XJ
Lu XJ, Miao RH, Li XQ. Combination of selective arterial infusion chemotherapy with radiotherapy in the treatment of advanced esophageal carcinoma. Chin J Clin Oncol 1995;22:4-265.
 
331 - Roussel A
Roussel A, Haegele P, Paillot B, et al. Results of the EORTC GTCCG phase III trial of irradiation versus irradiation and CDDP in inoperable esophageal cancer. Proc Am Soc Clin Oncol 1994;13. Abstract.
 
332 - Roussel A
Roussel A, Bleiberg H, Dalesio O, Jacob JH, Haegele P, Jung GM, et al. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys 1989;16:67-72.
 
333 - Slabber CF
Slabber CF, Nel JS, Schoeman L, Burger W, Falkson G, Falkson CI. A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 1998;21:462-5.
 
334 - Zhang ZF
Zhang ZF. [Radiation combined with bleomycin in esophageal carcinoma – a randomized study of 99 patients]. Zhonghua Zhong Liu Za Zhi 1984;6:372-4.
 
335 - Zhou JC
Zhou JC. [Randomized trial of combined chemotherapy including high dose cisplatin and radiotherapy for esophageal cancer]. Zhonghua Zhong Liu Za Zhi 1991;13:291-4.
 
336 - Wong R
Wong R, Malthaner RA. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2001;(2):CD002092.
 
337 - Wong RK
Wong RK, Malthaner RA, Zuraw L, Rumble RB. Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys 2003;55:930-42 .
 
338 - Minsky BD
Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74.
 
339 - Jeremic B
Jeremic B, Shibamoto Y, Acimovic L, Matovic Z, Milicic B, Milisavljevic S, et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 1998;40:1061-6.
 
340 - Safran H
Safran H, Gaissert H, Akerman P, Hesketh PJ, Chen MH, Moore T, et al. Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer. Cancer Invest 2001;19:1-7.
 
341 - Bozzetti F
Bozzetti F, Cozzaglio L, Gavazzi C, Bidoli P, Bonfanti G, Montalto F, et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori 1998;84:681-6.
 
342 - Sikora SS
Sikora SS, Ribeiro U, Kane JM, Landreneau RJ, Lembersky B, Posner MC. Role of nutrition support during induction chemoradiation therapy in esophageal cancer. J Parenter Enteral Nutr 1998;22:18-21.
 
343 - Flores AD
Flores AD, Nelems B, Evans K, Hay JH, Stoller J, Jackson SM. Impact of new radiotherapy modalities on the surgical management of cancer of the esophagus and cardia. Int J Radiat Oncol Biol Phys 1989;17:937-44; Hishikawa, Radther Oncol 1991: zie p. 192 concept, Cooper 1999.
 
344 - Loder RE
Loder RE. Routine pre-operative chest radiography. 1977 compared with 1955 at Peterborough District General Hospital. Anaesthesia 1978;33:972-4.
 
345 - Roizen MF
Roizen MF. More preoperative assessment by physicians and less by laboratory tests.N Engl J Med 2000;342:204-5.
 
346 - Sagel SS
Sagel SS, Evens RG, Forrest JV, Bramson RT. Efficacy of routine screening and lateral chest radiographs in a hospital- based population. N Engl J Med 1974;291:1001-4.
 
347 - Kaplan EB
Kaplan EB, Sheiner LB, Boeckmann AJ, Roizen MF, Beal SL, Cohen SN, et al. The usefulness of preoperative laboratory screening. JAMA 1985;253:3576-81.
 
348 - Macario A
Macario A, Roizen MF, Thisted RA, Kim S, Orkin FK, Phelps C. Reassessment of preoperative laboratory testing has changed the test-ordering patterns of physicians. Surg Gynecol Obstet 1992;175:539-47.
 
349 - Velanovich V
Velanovich V. The value of routine preoperative laboratory testing in predicting postoperative complications: a multivariate analysis. Surgery 1991;109(3 Pt 1):236-43.
 
350 - Narr BJ
Narr BJ, Warner ME, Schroeder DR, Warner MA. Outcomes of patients with no laboratory assessment before anesthesia and a surgical procedure. Mayo Clin Proc 1997;72:505-9.
 
351 - Schein OD
Schein OD, Katz J, Bass EB, Tielsch JM, Lubomski LH, Feldman MA, et al. The value of routine preoperative medical testing before cataract surgery. Study of Medical Testing for Cataract Surgery. N Engl J Med 2000;342:168-75.
 
352 - Preoperative tests
Preoperative tests, the use of routine preoperative tests for elective surgery. NICE (National Institute for Clinical Excellence) (ed). Guideline 3. 2003. Report.
 
353 - Garcia-Miguel FJ
Garcia-Miguel FJ, Serrano-Aguilar PG, Lopez-Bastida J. Preoperative assessment. Lancet 2003;362:1749-57.
 
354 - CBO
Toetsing van het preoperatief onderzoek. CBO, 1986.
 
355 - Bozzetti F
Bozzetti F, Cozzaglio L, Gavazzi C, Bidoli P, Bonfanti G, Montalto F, et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori 1998;84:681-6.
 
356 - Dunne-Daly CF
Dunne-Daly CF. Principles of radiotherapy and radiobiology. Semin Oncol Nurs 1999;15:250-9.
 
357 - Kelley DJ
Kelley DJ, Wolf R, Shaha AR, Spiro RH, Bains MS, Kraus DH, et al. Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg 1995;170:427-31.
 
358 - Mercer CD
Mercer CD, Mungara A. Enteral feeding in esophageal surgery. Nutrition 1996;12:200-1.
 
359 - Poroch D
Poroch D. The effect of preparatory patient education on the anxiety and satisfaction of cancer patients receiving radiation therapy. Cancer Nurs 1995;18:206-14.
 
360 - Quinn KL
Quinn KL, Reedy A. Esophageal cancer: therapeutic approaches and nursing care. Semin Oncol Nurs 1999;15:17-25.
 
361 - Parshad R
Parshad R, Misra MC, Joshi YK, Kapur BM. Role of enteral hyperalimentation in patients of carcinoma oesophagus. Indian J Med Res 1993;98:165-9.
 
362 - Steyn RS
Steyn RS, Grenier I, Darnton SJ, Cullen MH, Matthews HR. Weight gain as an indicator of response to chemotherapy for oesophageal carcinoma. Clin Oncol (R Coll Radiol) 1995;7:382-4 .
 
363 - Meunier B
Meunier B, Spiliopoulos Y, Stasik C, Lakehal M, Malledant Y, Launois B. Retrosternal bypass operation for unresectable squamous cell cancer of the esophagus. Ann Thorac Surg 1996;62:373-7.
 
364 - Postma B
Postma B, Wesdorp RIC. Depletie of ondervoeding in het ziekenhuis. In: Stasse-Wolthuis M, Douwes AC (eds). Ondervoeding in het ziekenhuis. Houten: Bohn Stafleu Van Loghum, 1993.
 
365 - Baldwin C
Baldwin C, Parsons T, Logan S. Dietary advice for illness-related malnutrition in adults. Cochrane Database Syst Rev 2004;(3).
 
366 - Bruun LI
Bruun LI, Bosaeus I, Bergstad I, Nygaard K. Prevalence of malnutrition in surgical patients: evaluation of nutritional support and documentation. Clin Nutr 1999;18:141-7.
 
367 - Meguid MM
Meguid MM, Campos AC, Hammond WG. Nutritional support in surgical practice: Part I. Am J Surg 1990;159:345-58.
 
368 - Blazeby JM
Blazeby JM, Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut 2001;49:227-30.
 
369 - ASPEN Board of Directors and the Clinical Guidelines
ASPEN Board of Directors and the Clinical Guidelines, Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002;26(1 Suppl.):1SA-138SA.
 
370 - Jolliet P
Jolliet P, Pichard C, Biolo G, Chiolero R, Grimble G, Leverve X, et al. Enteral nutrition in intensive care patients: a practical approach. Clin Nutr 1999;18:47-56.
 
371 - Khaodhiar L
Khaodhiar L, McCowen K, Bistrian B. Perioperative hyperglycemia, infection or risk? Curr Opin Clin Nutr Metab Care 1999;2:79-82.
 
372 - Thorell A
Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999;2:69-78.
 
373 - Nygren J
Nygren J, Thorell A, Ljungqvist O. Preoperative oral carbohydrate nutrition: an update. Curr Opin Clin Nutr Metab Care 2001;4:255-9.
 
374 - Soop M
Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E576-83.
 
375 - Ljungqvist O
Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery 2000;128:757-60.
 
376 - MacFie J
MacFie J, Woodcock NP, Palmer MD, Walker A, Townsend S, Mitchell CJ. Oral dietary supplements in pre- and postoperative surgical patients: a prospective and randomized clinical trial. Nutrition 2000;16:723-8.
 
377 - Tepaske R
Tepaske R. Immunonutritie bij intensive care patiënten. Ned Ver Intensive Care Monitor 2001;4:19-29.
 
378 - Beale RJ
Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999;27:2799-805.
 
379 - Heyland DK
Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001;286:944-53.
 
380 - Heys SD
Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999;229:467-77.
 
381 - Senkal M
Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, Frei A, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999;134:1309-16.
 
382 - Atkinson S
Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immu- nonutrition in the critically ill. Guy’s Hospital Intensive Care Group. Crit Care Med 1998;26:1164-72.
 
383 - Bertolini G
Bertolini G, Iapichino G, Radrizzani D, Facchini R, Simini B, Bruzzone P, et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 2003;29:834-40 .
 
384 - Bruce DM
Bruce DM, Bremner CG, Park KGM, Heys SD, Meester TR de. Perioperative nutrition for patients undergoing resection of oesophageal, gastric and pancreatic malignancy. Cochrane Database Syst Rev 2004;(3).
 
385 - Riboli EB
Riboli EB, Bertoglio S, Arnulfo G, Terrizzi A. Treatment of esophageal anastomotic leakages after cancer resection. The role of total parenteral nutrition. J Parenter Enteral Nutr 1986;10:82-5.
 
386 - Sauerwein HP
Sauerwein HP, Romijn JA, Soeters PB. Kunstmatige voeding bij door ziekte veranderde stofwisseling. 2e ed. Maarssen: Elsevier/Bunge, 1998.
 
387 - Sato N
Sato N, Oyamatsu M, Tsukada K, Suzuki T, Hatakeyama K, Muto T. Serial changes in contribution of substrates to energy expenditure after transthoracic esophagectomy for cancer. Nutrition 1997;13:100-3.
 
388 - Baba M
Baba M, Aikon T, Natsugoe S, Kusano C, Shimada M, Nakano S, et al. Quality of life following esophagectomy with three-field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy. Dis Esophagus 1998;11:28-34.
 
389 - Boer AG de
Boer AG de, Genovesi PI, Sprangers MA, Sandick JW van, Obertop H, Lanschot JJ van. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000;87:1716-21.
 
390 - Gawad KA
Gawad KA, Hosch SB, Bumann D, Lubeck M, Moneke LC, Bloechle C, et al. How important is the route of recon- struction after esophagectomy: a prospective randomized study. Am J Gastroenterol 1999;94:1490-6.
 
391 - McLarty AJ
McLarty AJ, Deschamps C, Trastek VF, Allen MS, Pairolero PC, Harmsen WS. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997;63:1568-72.
 
392 - Brooks JA
Brooks JA, Kesler KA, Johnson CS, Ciaccia D, Brown JW. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 2002;81:185-94.
 
393 - Baba M
Baba M, Aikou T, Natsugoe S, Kusano C, Shimada M, Kimura S, et al. Appraisal of ten-year survival following eso- phagectomy for carcinoma of the esophagus with emphasis on quality of life. World J Surg 1997;21:282-5.
 
394 - Akkersdijk WL
Akkersdijk WL, Vos A, Werken C van der. [Feeding tubes for tube feeding]. Ned Tijdschr Geneeskd 1998;142:557-61.
 
395 - Mathus-Vliegen EMH
Mathus-Vliegen EMH, Hackmann R. Aspecten van klinische voeding. Utrecht: Lemma, 1995.
 
396 - Layon AJ
Layon AJ, Florete OG Jr, Day AL, Kilroy RA, James PB, McGuigan JE. The effect of duodenojejunal alimentation on gastric pH and hormones in intensive care unit patients. Chest 1991;99:695-702.
 
397 - Russell MK
Russell MK, Charney P. Is there a role for specialized enteral nutrition in the intensive care unit? Nutr Clin Pract 2002;17:156-68.
 
398 - Tapia J
Tapia J, Murguia R, Garcia G, los Monteros PE, Onate E. Jejunostomy: techniques, indications, and complications. World J Surg 1999;23:596-602.
 
399 - Wakefield SE
Wakefield SE, Mansell NJ, Baigrie RJ, Dowling BL. Use of a feeding jejunostomy after oesophagogastric surgery. Br J Surg 1995;82:811-3.
 
400 - Brock MV
Brock MV, Venbrux AC, Heitmiller RF. Percutaneous replacement jejunostomy after esophagogastrectomy. J Gastrointest Surg 2000;4:407-10 .
 
401 - Aiko S
Aiko S, Yoshizumi Y, Sugiura Y, Matsuyama T, Naito Y, Matsuzaki J, et al. Beneficial effects of immediate enteral nutrition after esophageal cancer surgery. Surg Today 2001;31:971-8.
 
402 - Braga M
Braga M, Gianotti L, Gentilini O, Parisi V, Salis C, Carlo V di. Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Crit Care Med 2001;29:242-8.
 
403 - Eyer SD
Eyer SD, Micon LT, Konstantinides FN, Edlund DA, Rooney KA, Luxenberg MG, et al. Early enteral feeding does not attenuate metabolic response after blunt trauma. J Trauma 1993;34:639-43.
 
404 - Heyland D
Heyland D, Cook DJ, Winder B, Brylowski L, Mark H van de, Guyatt G. Enteral nutrition in the critically ill patient: a prospective survey. Crit Care Med 1995;23:1055-60.
 
405 - Marik PE
Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med 2001;29:2264-70.
 
406 - Oudemans-van Straaten HM
Oudemans-van Straaten HM. Maatregelen ter bevordering van maagontlediging bij enterale voeding. Neth J Crit Care 2004;6:18 -27.
 
407 - Bell SJ
Bell SJ, Borlase BC, Swails W, Dascoulias K, Ainsley B, Forse RA. Experience with enteral nutrition in a hospital population of acutely ill patients. J Am Diet Assoc 1994;94:414-9.
 
408 - Salasidis R
Salasidis R, Fleiszer T, Johnston R. Air insufflation technique of enteral tube insertion: a randomized, controlled trial. Crit Care Med 1998;26:1036-9.
 
409 - Schwartz DB
Schwartz DB. Enhanced enteral and parenteral nutrition practice and outcomes in an intensive care unit with a hospital-wide performance improvement process. JAm Diet Assoc 1996;96:484-9.
 
410 - Heyland DK
Heyland DK. Nutritional support in the critically ill patients. A critical review of the evidence. Crit Care Clin 1998;14:423-40.
 
411 - Bozzetti F
Bozzetti F, Gavazzi C, Miceli R, Rossi N, Mariani L, Cozzaglio L, et al. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial.J Parenter Enteral Nutr 2000;24:7-14.
 
412 - Bricard H
Bricard H, Deshayes JP, Sillard B, Lefrancois C, Delassus P, Lochu T, et al. [Antibiotic prophylaxis in surgery of the esophagus].Ann Fr Anesth Reanim 1994;13(5 suppl):S161-8 .
 
413 - Giercksky KE
Giercksky KE, Danielsen S. Antimicrobial prophylaxis in upper gastrointestinal, biliary, stomach and oesophageal surgery. Scand J Infect Dis Suppl 1990;70:45-51 .
 
414 - Riedl S
Riedl S, Peter B, Geiss HK, Aulmann M, Bach A, Lehnert T. [Microbiological and clinical effects of selective bowel decontamination in transthoracic resection of carcinoma of the esophagus and cardia]. Chirurg 2001;72:1160-70.
 
415 - Sharpe DA
Sharpe DA, Renwick P, Mathews KH, Moghissi K. Antibiotic prophylaxis in oesophageal surgery. Eur J Cardiothorac Surg 1992;6:561-4.
 
416 - Tetteroo GW
Tetteroo GW, Wagenvoort JH, Castelein A, Tilanus HW, Ince C, Bruining HA. Selective decontamination to reduce gram-negative colonisation and infections after oesophageal resection. Lancet 1990;335:704-7.
 
417 - Jonge E de
Jonge E de, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial.Lancet 2003;362:1011-6.
 
418 - D’Amico R
D’Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998;316:1275-85.
 
419 - Kollef MH
Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. Chest 1994;105:1101-8.
 
420 - Nathens AB
Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 1999;134:170-6.
 
421 - Nieuwenhoven CA van
Nieuwenhoven CA van, Buskens E, Tiel FH van, Bonten MJ. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA 2001;286:335-40.
 
422 - Bock M
Bock M, Muller J, Bach A, Bohrer H, Martin E, Motsch J. Effects of preinduction and intraoperative warming during major laparotomy. Br J Anaesth 1998;80:159-63 .
 
423 - Caldwell MT
Caldwell MT, Murphy PG, Page R, Walsh TN, Hennessy TP. Timing of extubation after oesophagectomy. Br J Surg 1993;80:1537-9.
 
424 - Kurz A
Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group.N Engl J Med 1996;334:1209-15.
 
425 - Lenhardt R
Lenhardt R, Marker E, Goll V, Tschernich H, Kurz A, Sessler DI, et al. Mild intraoperative hypothermia prolongs postanesthetic recovery. Anesthesiology 1997;87:1318-23.
 
426 - Macario A
Macario A, Dexter F. What are the most important risk factors for a patient’s developing intraoperative hypothermia? Anesth Analg 2002;94:215-20.
 
427 - Schmied H
Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996;347:289-92.
 
428 - Nieuwenhoven CA van
Nieuwenhoven CA van, Buskens E, Tiel FH van, Bonten MJ. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA 2001;286:335-40.
 
429 - Winkler M
Winkler M, Akca O, Birkenberg B, Hetz H, Scheck T, Arkilic CF, et al. Aggressive warming reduces blood loss during hip arthroplasty. Anesth Analg 2000;91:978-84 .
 
430 - Mitchell AM
Mitchell AM, Kennedy RR. Preoperative core temperatures in elective surgical patients show an unexpected skewed distribution. Can J Anaesth 2001;48:850-3.
 
431 - Sessler DI
Sessler DI. Perioperative heat balance. Anesthesiology 2000;92:578-96.
 
432 - Stoneham M
Stoneham M, Howell S, Neill F. Heat loss during induction of anaesthesia for elective aortic surgery. Anaesthesia 2000;55:79-82.
 
433 - Joris J
Joris J, Ozaki M, Sessler DI, Hardy AF, Lamy M, McGuire J, et al. Epidural anesthesia impairs both central and peripheral thermoregulatory control during general anesthesia. Anesthesiology 1994;80:268-77.
 
434 - Kongsayreepong S
Kongsayreepong S, Chaibundit C, Chadpaibool J, Komoltri C, Suraseranivongse S, Suwannanonda P, et al. Predictor of core hypothermia and the surgical intensive care unit. Anesth Analg 2003;96:826-33.
 
435 - Kurz A
Kurz A, Plattner O, Sessler DI, Huemer G, Redl G, Lackner F. The threshold for thermoregulatory vasoconstriction during nitrous oxide/isoflurane anesthesia is lower in elderly than in young patients. Anesthesiology 1993;79:465-9.
 
436 - Frank SM
Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial.JAMA 1997;277:1127-34 .
 
437 - Motamed S
Motamed S, Klubien K, Edwardes M, Mazza L, Carli F. Metabolic changes during recovery in normothermic versus hypothermic patients undergoing surgery and receiving general anesthesia and epidural local anesthetic agents. Anesthesiology 1998;88:1211-8.
 
438 - Forstot RM
Forstot RM. The etiology and management of inadvertent perioperative hypothermia. J Clin Anesth 1995;7:657-74.
 
439 - Ng SF
Ng SF, Oo CS, Loh KH, Lim PY, Chan YH, Ong BC. A comparative study of three warming interventions to deter- mine the most effective in maintaining perioperative normothermia. Anesth Analg 2003;96:171-6.
 
440 - Berghe G van den
Berghe G van den, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 2001;345:1359-67 .
 
441 - Gan TJ
Gan TJ, Soppitt A, Maroof M, Moalem H el, Robertson KM, Moretti E, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology 2002;97:820-6.
 
442 - Moretti EW
Moretti EW, Robertson KM, Moalem H el, Gan TJ. Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesth Analg 2003;96:611-7.
 
443 - Allen DB
Allen DB, Maguire JJ, Mahdavian M, Wicke C, Marcocci L, Scheuenstuhl H, et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997;132:991-6.
 
444 - Hopf HW
Hopf HW, Hunt TK, West JM, Blomquist P, Goodson WH III, Jensen JA, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997;132:997-1004.
 
445 - Arkilic CF
Arkilic CF, Taguchi A, Sharma N, Ratnaraj J, Sessler DI, Read TE, et al. Supplemental perioperative fluid administration increases tissue oxygen pressure. Surgery 2003;133:49-55.
 
446 - Brandstrup B
Brandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen K, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial.Ann Surg 2003;238:641-8.
 
447 - Lobo DN
Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Allison SP. Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial. Lancet 2002;359:1812-8.
 
448 - Holte K
Holte K, Kehlet H. Compensatory fluid administration for preoperative dehydration – does it improve outcome? Acta Anaesthesiol Scand 2002;46:1089-93.
 
449 - Holte K
Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002;89:622-32.
 
450 - Bunn F
Bunn F, Alderson P, Hawkins V. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2003;(1): CD001319.
 
451 - Waters JH
Waters JH, Gottlieb A, Schoenwald P, Popovich MJ, Sprung J, Nelson DR. Normal saline versus lactated Ringer’s solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 2001;93:817-22.
 
452 - Lang K
Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001;93:405-9.
 
453 - Huttner I
Huttner I, Boldt J, Haisch G, Suttner S, Kumle B, Schulz H. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. Br J Anaesth 2000;85:417-23.
 
454 - Treib J
Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999;25:258-68.
 
455 - Huraux C
Huraux C, Ankri AA, Eyraud D, Sevin O, Menegaux F, Coriat P, et al. Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood group. Anesth Analg 2001;92:1396-401.
 
456 - Aken WG van
Aken WG van, Buiting AMJ, Casparie AF, Castel A, Dinelaar RB, Everdingen JJE van, et al. Richtlijn Bloedtransfusie. Alphen a/d Rijn: Van Zuiden Communications BV, 2004.
 
457 - Beattie WS
Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis.Anesth Analg 2001;93:853-8.
 
458 - Rodgers A
Rodgers A, Walker N, Schug S, McKee A, Kehlet H, Zundert A van, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000;321:1493.
 
459 - Ballantyne JC
Ballantyne JC, Carr DB, Ferranti S de, Suarez T, Lau J, Chalmers TC, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg 1998;86:598-612.
 
460 - Block BM
Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA 2003;290:2455-63 .
 
461 - Rigg JR
Rigg JR, Jamrozik K, Myles PS, Silbert BS, Peyton PJ, Parsons RW, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 2002;359:1276-82 .
 
462 - Peyton PJ
Peyton PJ, Myles PS, Silbert BS, Rigg JA, Jamrozik K, Parsons R. Perioperative epidural analgesia and outcome after major abdominal surgery in high-risk patients. Anesth Analg 2003;96:548-table.
 
463 - Park WY
Park WY, Thompson JS, Lee KK. Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study. Ann Surg 2001;234:560-9.
 
464 - Terai T
Terai T, Yukioka H, Fujimori M. Administration of epidural bupivacaine combined with epidural morphine after esophageal surgery. Surgery 1997;121:359-65.
 
465 - Kahn L
Kahn L, Baxter FJ, Dauphin A, Goldsmith C, Jackson PA, McChesney J, et al. A comparison of thoracic and lumbar epidural techniques for post-thoracoabdominal esophagectomy analgesia. Can J Anaesth 1999;46(5 Pt 1):415-22.
 
466 - Chandrashekar MV
Chandrashekar MV, Irving M, Wayman J, Raimes SA, Linsley A. Immediate extubation and epidural analgesia allow safe management in a high-dependency unit after two-stage oesophagectomy. Results of eight years of experience in a specialized upper gastrointestinal unit in a district general hospital. Br J Anaesth 2003;90:474-9.
 
467 - Tsui SL
Tsui SL, Law S, Fok M, Lo JR, Ho E, Yang J, et al. Postoperative analgesia reduces mortality and morbidity after esophagectomy. Am J Surg 1997;173:472-8.
 
468 - Brodner G
Brodner G, Pogatzki E, van Aken H, Buerkle H, Goeters C, Schulzki C, et al. A multimodal approach to control post- operative pathophysiology and rehabilitation in patients undergoing abdominothoracic esophagectomy. Anesth Analg 1998;86:228-34.
 
469 - Avendano CE
Avendano CE. Pulmonary complications after esophagectomy. Ann Thorac Surg 2002;3:922-6 .
 
470 - Bartels H
Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.Br J Surg 1998;85:840-4 .
 
471 - Bollschweiler E
Bollschweiler E, Schroder W, Holscher AH, Siewert JR. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 2000;87:1106-10 .
 
472 - Karl RC
Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 2000;231:635-43.
 
473 - Patti MG
Patti MG, Wiener-Kronish JP, Way LW, Pellegrini CA. Impact of transhiatal esophagectomy on cardiac and respiratory function. Am J Surg 1991;162:563-6.
 
474 - Sato N
Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, Iwaya T, et al. Randomized study of the benefits of preoperative cortico- steroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002;236:2-190.
 
475 - Fagevik OM
Fagevik OM, Hahn I, Nordgren S, Lonroth H, Lundholm K. Randomized controlled trial of prophylactic chest physio- therapy in major abdominal surgery. Br J Surg 1997;84:1535-8.
 
476 - Gosselink R
Gosselink R, Schrever K, Cops P, Witvrouwen H, Leyn P de, Troosters T, et al. Incentive spirometry does not enhance recovery after thoracic surgery. Crit Care Med 2000;28:679-83.
 
477 - Caldwell MT
Caldwell MT, Murphy PG, Page R, Walsh TN, Hennessy TP. Timing of extubation after oesophagectomy. Br J Surg 1993;80:1537-9.
 
478 - Nieuwenhoven CA van
Nieuwenhoven CA van, Buskens E, Tiel FH van, Bonten MJ. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA 2001;286:335-40.
 
479 - Yap FH
Yap FH, Lau JY, Joynt GM, Chui PT, Chan AC, Chung SS. Early extubation after transthoracic oesophagectomy. Hong Kong Med J 2003;9:98-102 .
 
480 - Bartels H
Bartels H. [Early extubation vs. late extubation after esophagus resection: a randomized, prospective study]. [German]. Langenbecks Archiv für Chirurgie Supplement Kongressband 1998;115:1074-6.
 
481 - Chandrashekar MV
Chandrashekar MV, Irving M, Wayman J, Raimes SA, Linsley A. Immediate extubation and epidural analgesia allow safe management in a high-dependency unit after two-stage oesophagectomy. Results of eight years of experience in a specialized upper gastrointestinal unit in a district general hospital. Br J Anaesth 2003;90:474-9.
 
482 - Kita T
Kita T, Mammoto T, Kishi Y. Fluid management and postoperative respiratory disturbances in patients with trans- thoracic esophagectomy for carcinoma. J Clin Anesth 2002;14:252-6.
 
483 - Kinugasa S
Kinugasa S, Tachibana M, Yoshimura H, Dhar DK, Shibakita M, Ohno S, et al. Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann Thorac Surg 2001;71:414-8.
 
484 - Brooks-Brunn JA
Brooks-Brunn JA. Esophageal cancer: an overview. Medsurg Nurs 2000;9:248-54.
 
485 - Mills ME
Mills ME, Sullivan K. Patients with operable oesophageal cancer: their experience of information-giving in a regional thoracic unit. J Clin Nurs 2000;9:236-46.
 
486 - Quinn KL
Quinn KL, Reedy A. Esophageal cancer: therapeutic approaches and nursing care. Semin Oncol Nurs 1999;15:17-25.
 
487 - Held JL
Held JL, Peahota A. Nursing care of patients with esophageal cancer. Oncol Nurs Forum 1992;19:627-34.
 
488 - Bousamra M
Bousamra M, Haasler GB, Parviz M. A decade of experience with transthoracic and transhiatal esophagectomy. Am J Surg 2002;183:162-7.
 
489 - Marmuse JP
Marmuse JP, Koka VN, Guedon C, Benhamou G. Surgical treatment of carcinoma of the proximal esophagus. Am J Surg 1995;169:386-90.
 
490 - Cope C
Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. J Vasc Interv Radiol 1998;9:727-34.
 
491 - Fujiwara Y
Fujiwara Y, Nakagawa K, Kusunoki M, Hatada T, Yamamura T, Utsunomiya J. Massive pleural effusion and ascites resulting from esophagectomy with extensive lymphadenectomy for cancer of the abdominal esophagus. Hepatogastroenterology 1999;46:290-4.
 
492 - Gier HH de
Gier HH de, Balm AJ, Bruning PF, Gregor RT, Hilgers FJ. Systematic approach to the treatment of chylous leakage after neck dissection. Head Neck 1996;18:347-51.
 
493 - Rubin JW
Rubin JW, Moore HV, Ellison RG. Chylothorax: therapeutic alternatives. Am Surg 1977;43:292-7.
 
494 - Sauvanet A
Sauvanet A, Baltar J, Mee J le, Belghiti J. Diagnosis and conservative management of intrathoracic leakage after oesophagectomy. Br J Surg 1998;85:1446-9.
 
495 - Vandermeulen E
Vandermeulen E, Aken H van. Acute postoperatieve pijntherapie. Ned Tijdschr Geneeskd 1994;50:1067-78.
 
496 - Dorrepaal KL
Dorrepaal KL, Aaronson NK, Dam FS van. Pain experience and pain management among hospitalized cancer patients. A clinical study. Cancer 1989;63:593-8.
 
497 - Yates P
Yates P, Dewar A, Edwards H, Fentiman B, Najman J, Nash R, et al. The prevalence and perception of pain amongst hospital in-patients. J Clin Nurs 1998;7:521-30.
 
498 - Chapman PJ
Chapman PJ, Ganendran A, Scott RJ, Basford KE. Attitudes and knowledge of nursing staff in relation to management of postoperative pain. Aust N Z J Surg 1987;57:447-50 .
 
499 - Hiele M
Hiele M. De acute buik. Ned Tijdschr Geneeskd 2000;56:1459-63.
 
500 - Rubin GJ
Rubin GJ, Hotopf M. Systematic review and meta-analysis of interventions for postoperative fatigue. Br J Surg 2002;89:971-84.
 
501 - Servaes P
Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions.Eur J Cancer 2002;38:27-43 .
 
502 - Bachmann MO
Bachmann MO, Alderson D, Edwards D, Wotton S, Bedford C, Peters TJ, et al. Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers. Br J Surg 2002;89:914-22.
 
503 - Birkmeyer JD
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-37.
 
504 - Birkmeyer JD
Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-27.
 
505 - Dickson GH
Dickson GH, Waters R, Bull J, Kaul V, Sitzia J. Should we continue oesophageal surgery in a district general hospital? A review of 200 consecutive cases. Ann R Coll Surg Engl 2001;83:167-71.
 
506 - Dimick JB
Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg 2003;75:337-41.
 
507 - Dudley RA
Dudley RA. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA 2000;9:1159-66.
 
508 - Finlayson EV
Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg 2003;138:721-5.
 
509 - Halm EA
Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med 2002;137:511-20.
 
510 - Kuo EY
Kuo EY, Chang Y, Wright CD. Impact of hospital volume on clinical and economic outcomes for esophagectomy. Ann Thorac Surg 2001;72:1118-24.
 
511 - McCulloch P
McCulloch P, Ward J, Tekkis PP. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 2003;327:1192-7.
 
512 - Obertop H
Obertop H. [Practice makes perfect. The favourable effect of experience on the outcome of care]. Ned Tijdschr Geneeskd 2004;148:1327-9.
 
513 - Swisher SG
Swisher SG, Deford L, Merriman KW, Walsh GL, Smythe R, Vaporicyan A, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000;119:1126-32.
 
514 - Lanschot JJ van
Lanschot JJ van, Hulscher JB, Buskens CJ, Tilanus HW, Kate FJ ten, Obertop H. Hospital volume and hospital mortality for esophagectomy. Cancer 2001;91:1574-8.
 
515 - Dimick JB
Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality: the problem with small sample size. JAMA 2004;292:847-51.
 
516 - Virgo KS
Virgo KS, Johnson FE, Naunheim KS. Follow-up of patients with thoracic malignancies. Surg Oncol Clin N Am 1999;8:355-69.
 
517 - Goodnight J
Goodnight J, Venook A, Ames M, Taylor C, Gilden R, Figlin RA. Practice Guidelines for Esophageal Cancer. Cancer J Sci Am 1996;2:S37.
 
518 - Johnson FE
Johnson FE, Virgo KS. Cancer patient follow up. St. Louis: Mosby, 1997.
 
519 - Marsh JC
Marsh JC. Esophageal cancer. In: Fischer DS (ed). Follow up of cancer: a handbook for physicians. Philadelphia: Lippincott-Raven Publishers, 1996:34-5.
 
520 - Wiggers T
Wiggers T. [Follow-up after oncological surgery]. Ned Tijdschr Geneeskd 2001;145:2261-4 .
 
521 - Palma GD de
Palma GD de, Matteo E di, Romano G, Fimmano A, Rondinone G, Catanzano C. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc 1996;43:478-82.
 
522 - Knyrim K
Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993;329:1302-7.
 
523 - Siersema PD
Siersema PD, Hop WC, Dees J, Tilanus HW, Blankenstein M van. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 1998;47:113-20.
 
524 - Vakil N
Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol 2001;96:1791-6.
 
525 - Siersema PD
Siersema PD, Hop WC, Blankenstein M van, Tilburg AJ van, Bac DJ, Homs MY, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001;54:145-53.
 
526 - Sabharwal T
Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 2003;52:7-926.
 
527 - Homs MY
Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJA, Bartelsman J-FWM, et al. Single dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer; multicenter, randomised trial. Lancet 2004;364:1497-504.
 
528 - Dumonceau JM
Dumonceau JM, Cremer M, Lalmand B, Deviere J. Esophageal fistula sealing: choice of stent, practical management, and cost. Gastrointest Endosc 1999;49:70-8 .
 
529 - May A
May A, Ell C. Palliative treatment of malignant esophagorespiratory fistulas with Gianturco-Z stents. A prospective clinical trial and review of the literature on covered metal stents.Am J Gastroenterol 1998;93:532-5.
 
530 - Siersema PD
Siersema PD, Schrauwen SL, Blankenstein M van, Steyerberg EW, Gaast A van der, Tilanus HW, et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 2001;54:579-86.
 
531 - Reed CE
Reed CE, Marsh WH, Carlson LS, Seymore CH, Kratz JM. Prospective, randomized trial of palliative treatment for unresectable cancer of the esophagus. Ann Thorac Surg 1991;51:552-5.
 
532 - Schmid EU
Schmid EU, Alberts AS, Greeff F, Terblanche AP, Schoeman L, Burger W, et al. The value of radiotherapy or chemo- therapy after intubation for advanced esophageal carcinoma – a prospective randomized trial. Radiother Oncol 1993;28:27-30.
 
533 - Sargeant IR
Sargeant IR, Tobias JS, Blackman G, Thorpe S, Glover JR, Bown SG. Radiotherapy enhances laser palliation of malignant dysphagia: a randomised study. Gut 1997;40:362-9.
 
534 - Kharadi MY
C. Comparative evaluation of therapeutic approaches in stage III and IV squamous cell carcinoma of the thoracic esophagus with conventional radiotherapy and endoscopic treatment in combination and endoscopic treatment alone: a randomized prospective trial. Int J Radiat Oncol Biol Phys 1997;39:309-20.
 
535 - Flores AD
Flores AD, Nelems B, Evans K, Hay JH, Stoller J, Jackson SM. Impact of new radiotherapy modalities on the surgical management of cancer of the esophagus and cardia. Int J Radiat Oncol Biol Phys 1989;17:937-44.
 
536 - Hishikawa Y
Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol 1991;21:107-14.
 
537 - Taal BG
Taal BG, Aleman BM, Koning CC, Boot H. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer 1996;74:1452-7.
 
538 - Homs MY
Homs MY, Eijkenboom WM, Coen VL, Haringsma J, Blankenstein M van, Kuipers EJ, et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol 2003;66:327-32 .
 
539 - Jager J
Jager J, Langendijk H, Pannebakker M, Rijken J, Jong J de. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol 1995;37:237-40.
 
540 - Sur RK
Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.Int J Radiat Oncol Biol Phys 1998;40:447-53.
 
541 - Carter R
Carter R, Smith JS, Anderson JR. Palliation of malignant dysphagia using the Nd:YAG laser. World J Surg 1993;17:608-13.
 
542 - Fleischer D
Fleischer D, Kessler F, Haye O. Endoscopic Nd: YAG laser therapy for carcinoma of the esophagus: a new palliative approach. Am J Surg 1982;143:280-3 .
 
543 - Mason RC
Mason RC, Bright N, McColl I. Palliation of malignant dysphagia with laser therapy: predictability of results. Br J Surg 1991;78:1346-7.
 
544 - Pietrafitta JJ
Pietrafitta JJ, Bowers GJ, Dwyer RM. Prograde versus retrograde endoscopic laser therapy for the treatment of malignant esophageal obstruction: a comparison of techniques. Lasers Surg Med 1988;8:288-93.
 
545 - Sander R
Sander R, Hagenmueller F, Sander C, Riess G, Classen M. Laser versus laser plus afterloading with iridium-192 in the palliative treatment of malignant stenosis of the esophagus: a prospective, randomized, and controlled study. Gastrointest Endosc 1991;37:433-40.
 
546 - Spencer GM
Spencer GM, Thorpe SM, Blackman GM, Solano J, Tobias JS, Lovat LB, et al. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study. Gut 2002;50:224-7.
 
547 - Adam A
Adam A, Ellul J, Watkinson AF, Tan BS, Morgan RA, Saunders MP, et al. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 1997;202:344-8.
 
548 - Dallal HJ
Dallal HJ, Smith GD, Grieve DC, Ghosh S, Penman ID, Palmer KR. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001;54:549-57.
 
549 - Prosst RL
Prosst RL, Wolfsen HC, Gahlen J. Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 2003;35:1059-68.
 
550 - Hage M
Hage M, Siersema PD, Dekken H van, Steyerberg EW, Haringsma J, Vrie W van de, et al. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial. Gut 2004;53:785-90.
 
551 - Heier SK
Heier SK, Rothman KA, Heier LM, Rosenthal WS. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy. Gastroenterology 1995;109:63-72.
 
552 - Lightdale CJ
Lightdale CJ, Heier SK, Marcon NE, McCaughan J-SJ, Gerdes H, Overholt BF, et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 1995;42:507-12.
 
553 - Stringer S
Stringer S. Managing dysphagia in palliative care. Prof Nurse 1999;14:489-92.
 
554 - Grant MM
Grant MM, Rovera LM. Anorexia, cachexia, and dysphagia: the symptom experience. Semin Oncol Nurs 1995;11:266-71.
 
555 - Huber D
Huber D. Perspectives. My introduction to metallic esophageal stents with case reviews. Gastroenterol Nurs 1997; 20(2):61-2.
 
556 - Ragsdale JA
Ragsdale JA. Expandable esophageal wire stents. Gastroenterol Nurs 1996;19:44-52.
 
557 - Dunne-Daly CF
Dunne-Daly CF. Principles of radiotherapy and radiobiology. Semin Oncol Nurs 1999;15:250-9.
 
558 - Poroch D
Poroch D. The effect of preparatory patient education on the anxiety and satisfaction of cancer patients receiving radiation therapy. Cancer Nurs 1995;18:206-14.
 
559 - Quinn KL
Quinn KL, Reedy A. Esophageal cancer: therapeutic approaches and nursing care. Semin Oncol Nurs 1999;15:17-25.
 
560 - Doornik N
Doornik N, Vogel J, Wipkink A, Beijer S. Van wensdieet naar palliatieve voeding. Ontwikkelingen en dilemma’s in de voedingszorg voor patiënten met kanker en een zeer beperkte levensverwachting. Ned Tijdschr Diet 2000;55:262-7.
 
561 - Doornik N
Doornik N. Leidraad voor voedingsdeskundigen bij kanker. 3e ed. Haarlem: De Toorts, 2003.
 
562 - Roseveare CD
Roseveare CD, Patel P, Simmonds N, Goggin PM, Kimble J, Shepherd HA. Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. Eur J Gastroenterol Hepatol 1998;10:653-7.
 
563 - O’Donnell CA
O’Donnell CA, Fullarton GM, Watt E, Lennon K, Murray GD, Moss JG. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg 2002;89:985-92.
 
564 - Levard H
Levard H, Pouliquen X, Hay JM, Fingerhut A, Langlois-Zantain O, Huguier M, et al. 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research. Eur J Surg 1998;164:849-57.
 
565 - Mannell A
Mannell A, Becker PJ, Melissas J, Diamantes T. Intubation v. dilatation plus bleomycin in the treatment of advanced oesophageal cancer. The results of a prospective randomized trial. S Afr J Surg 1986;24:15-9.
 
566 - Webb A
Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997;15:261-7.
 
567 - Ross P
Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002;20:1996-2004.
 
568 - Bleiberg H
Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 1997;33:1216-20.
 
569 - Homs MY
Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJA, Bartelsman J-FWM, et al. Single dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer; multicenter, randomised trial.Lancet 2004;364:1497-504.
 
570 - Hulscher JB
Hulscher JB, Sandick JW van, Boer AG de, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9.
 
571 - Marmuse JP
Marmuse JP, Koka VN, Guedon C, Benhamou G. Surgical treatment of carcinoma of the proximal esophagus. Am J Surg 1995;169:386-90.
 
572 - Peracchia A
Peracchia A, Bardini R, Ruol A, Segalin A, Castoro C, Asolati M, et al. Surgical management of carcinoma of the hypopharynx and cervical esophagus. Hepatogastroenterology 1990;37:371-5.
 
573 - Triboulet JP
Triboulet JP, Mariette C, Chevalier D, Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg 2001;136:1164-70 .
 
574 - Hilgers FJ
Hilgers FJ, Ackerstaff AH. Comprehensive rehabilitation after total laryngectomy is more than voice alone. Folia Phoniatr Logop 2000;52:65-73.
 
575 - Bidoli P
Bidoli P, Bajetta E, Stani SC, De CD, Santoro A, Valente M, et al. Ten-year survival with chemotherapy and radiothe- rapy in patients with squamous cell carcinoma of the esophagus. Cancer 2002;94:352-61.
 
576 - Burmeister BH
Burmeister BH, Dickie G, Smithers BM, Hodge R, Morton K. Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 2000;126:205-8.
 
577 - Yu L
Yu L, Vikram B, Malamud S, Yudelman I, Nussbaum M, Beattie E. Chemotherapy rapidly alternating with twice-a- day accelerated radiation therapy in carcinomas involving the hypopharynx or esophagus: an update. Cancer Invest 1995;13:567-72.
 
578 - Bonavina L
Bonavina L. Early oesophageal cancer: results of a European multicentre survey. Groupe Européen pour l’Etude des Maladies de l’Oesophage. Br J Surg 1995;82:98-101.
 
579 - Holscher AH
Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett’s oesophagus.Br J Surg 1997;84:1470-3.
 
580 - Sandick JW van
Sandick JW van, Lanschot JJ van, Kate FJ ten, Offerhaus GJ, Fockens P, Tytgat GN, et al. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000;88:2429-37.
 
581 - Buttar NS
Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus. Gastrointest Endosc 2001;54:682-8.
 
582 - May A
May A, Gossner L, Pech O, Fritz A, Gunter E, Mayer G, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14:1085-91.
 
583 - Orringer MB
Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999;230:392-400.
 
584 - Lerut T
Lerut T, Leyn P de, Coosemans W, Raemdonck D van, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216:583-90.
 
585 - Siewert JR
Siewert JR, Roder JD. Lymphadenectomy in oesophageal cancer surgery. Dis Esophagus 1992;2:91-7.
 
586 - Akiyama H
Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-72.
 
587 - Malthaner R
Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. The Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001556.
 
588 - Turnbull AD
Turnbull AD, Ginsberg RJ. Options in the surgical treatment of esophageal carcinoma. Chest Surg Clin N Am 1994;4:315-29.
 
589 - May A
May A, Ell C. Palliative treatment of malignant esophagorespiratory fistulas with Gianturco-Z stents. A prospective clinical trial and review of the literature on covered metal stents. Am J Gastroenterol 1998;93:532-5.
 
590 - Nelson DB
Nelson DB, Axelrad AM, Fleischer DE, Kozarek RA, Silvis SE, Freeman ML, et al. Silicone-covered Wallstent pro- totypes for palliation of malignant esophageal obstruction and digestive-respiratory fistulas. Gastrointest Endosc 1997;45:31-7.
 
591 - Siersema PD
Siersema PD, Schrauwen SL, Blankenstein M van, Steyerberg EW, Gaast A van der, Tilanus HW, et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest Endosc 2001;54:579-86.
 
592 - Ilson DH
Ilson DH, Forastiere A, Arquette M, Costa F, Heelan R, Huang Y, et al. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J 2000;6:316-23.
 
593 - Gaast A van der
Gaast A van der, Kok TC, Kerkhofs L, Siersema PD, Tilanus HW, Splinter TA. Phase I study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced oesophageal cancer. Br J Cancer 1999;80:1052-7.
 
594 - Flores AD
Flores AD, Nelems B, Evans K, Hay JH, Stoller J, Jackson SM. Impact of new radiotherapy modalities on the surgical management of cancer of the esophagus and cardia. Int J Radiat Oncol Biol Phys 1989;17:937-44.
 
595 - Hishikawa Y
Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol 1991;21:107-14.
 
596 - Taal BG
Taal BG, Aleman BM, Koning CC, Boot H. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer 1996;74:1452-7 .
 
597 - Urba SG
Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-13
 
598 - Walsh TN
Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7 .
 
599 - Cooper JS
Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson J-AJ, Al Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
 
600 - Wong R
Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2001;(2):CD002092.
 
601 - Charles C
Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999;49:651-61.
 
602 - Jansen SJT. ‘Dokter
Jansen SJT. ‘Dokter, wat vindt u?’, de patiënt helpen beslissen. Kanker bij de oudere patiënt: wat is er anders. Boerhaavecursus, 2002:21-36.
 
603 - Gattellari M
Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med 2001;52:1865-78.
 
604 - Arora NK
Arora NK, McHorney CA. Patient preferences for medical decision making: who really wants to participate? Med Care 2000;38:335-41.
 
605 - Koppenol-van Hooijdonk M
Koppenol-van Hooijdonk M, Boxtel R van. De bespreekbaarheid van ziekte en een naderende dood bij niet-westerse patiënten. Ned Tijdschr Palliat Zorg 2002;3:65-9.
 
606 - Blanchard CG
Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med 1988;27:1139-45.
 
607 - Cassileth BR
Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and participation preferences among cancer patients. Ann Intern Med 1980;92:832-6.
 
608 - Boer AG de
Boer AG de, Genovesi PI, Sprangers MA, Sandick JW van, Obertop H, Lanschot JJ van. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000;87:1716-21.
 
609 - Sweed MR
Sweed MR, Schiech L, Barsevick A, Babb JS, Goldberg M. Quality of life after esophagectomy for cancer. Oncol Nurs Forum 2002;29:1127-31 .
 
610 - McLarty AJ
McLarty AJ, Deschamps C, Trastek VF, Allen MS, Pairolero PC, Harmsen WS. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997;63:1568-72.
 
611 - Watt E
Watt E, Whyte F. The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer.Eur J Cancer Care (Engl) 2003;12:183-93.
 
612 - Irvine D
Irvine D, Brown B, Crooks D, Roberts J, Browne G. Psychosocial adjustment in women with breast cancer. Cancer 1991;67:1097-117.
 
613 - Schrameijer F
Schrameijer F, Brunenberg W. Psychosciale zorg bij kankerpatiënten en hulpverleners over problemen en hulpaanbod. Utrecht: Nederlands Centrum Geestelijke Volksgezondheid, 1992.
 
614 - Nisso X
Nisso X. Verlost van kanker, nog altijd vermoeid. Tijdschr Kanker 2002;26:32-3.
 
615 - Sprangers MA
Sprangers MA. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 2002;41:229-37.
 
616 - Jenkins V
Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001;84:48-51.
 
617 - Ong LJM
Ong LJM, Hoos AM, Laarhoven FJ van, Molenaar S, Visser MRM. De arts als boodschapper. In: Haes JC de, Hoos AM, Everdingen JJ van (eds). Communiceren met patiënten. Maarssen: Elsevier/Bunge, 1999:49-62.
 
618 - Glavassevich M
Glavassevich M, McKibon A, Thomas S. Information needs of patients who undergo surgery for head and neck cancer. Can Oncol Nurs J 1995;5:9-11 .
 
619 - Ackerstaff AH
Ackerstaff AH, Hilgers FJ. Rehabilitation after head and neck cancer. In: Jones AS, Philips DE, Hilgers FJ (eds). Diseases of the head and neck and nose and throat. London: Arnold, 1998:435-48.
 
620 - Ontwikkeling van een informatieprotocol
Ontwikkeling van een informatieprotocol, 1997.
 
621 - Tattersall MH
Tattersall MH, Butow PN, Clayton JM. Insights from cancer patient communication research. Hematol Oncol Clin North Am 2002;16:731-43.
 
622 - Klein Poelhuis EH
Klein Poelhuis EH, Schadé E, Kiezebrink ML, Pruyn JFA, Razenberg PPA, Wijnberg AES. Bewaakte overgangen; continuiteit in de zorg voor patiënten met kanker. Eindhoven: IKZ, 1997.
 
623 - Detmar SB
Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH. How are you feeling? Who wants to know? Patients’ and oncologists’ preferences for discussing health-related quality-of-life issues. J Clin Oncol 2000;18:3295-301.
 
624 - Blazeby JM
Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003;39:1384-94.
 
625 - Trijsburg RW
Trijsburg RW, Knippenberg FC van, Rijpma SE. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 1992;54:489-517 .
 
626 - Meyer TJ
Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol 1995;14:101-8.
 
627 - Harten WH van
Harten WH van, Noort O van, Warmerdam R, Hendricks H, Seidel E. Assessment of rehabilitation needs in cancer patients. Int J Rehabil Res 1998;21:247-57.
 
628 - Mock V
Mock V, Olsen M. Current management of fatigue and anemia in patients with cancer. Semin Oncol Nurs 2003;19(4 suppl 2):36-41.
 
629 - Schwartz AL
Schwartz AL. Physical activity after a cancer diagnosis: psychosocial outcomes. Cancer Invest 2004;22:82-92.
 
630 - Helgeson VS
Helgeson VS, Cohen S, Schulz R, Yasko J. Education and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry 1999;56:340-7.
 
631 - Borne HW van den
Borne HW van den, Pruyn JFA. Lotgenotencontact bij kankerpatiënten. Assen: Van Gorcum, 1985.
 
632 - Abrams JA (2009)
Abrams JA, Buono DL, Strauss J, McBride RB, Hershman DL, Neugut AI. Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly. Cancer. 2009;115(21):4924-33.
 
633 - Alibakhshi A (2009)
Alibakhshi A, Aminian A, Mirsharifi R, Jahangiri Y, Dashti H, Karimian F. The effect of age on the outcome of esophageal cancer surgery. Ann. Thorac. Med. 2009;4(2):71-4.
 
634 - Allum WH (2009)
Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27(30):5062-7.
 
635 - Al-Sarira AA (2007)
Al-Sarira AA, David G, Willmott S, Slavin JP, Deakin M, Corless DJ. Oesophagectomy practice and outcomes in England. British Journal of Surgery. 2007;94(5):585-91.
 
636 - Barbour AP (2007)
Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, et al. Adenocarcinoma of the gastroesophageal junction: Influence of esophageal resection margin and operative approach on outcome. Ann. Surg. 2007;246(1):1-8.
 
637 - Barbour AP (2008)
Barbour AP, Lagergren P, Hughes R, Alderson D, Barham CP, Blazeby JM. Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg. 2008;95(1):80-4.
 
638 - Bedenne L (2007)
Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160-8.
 
639 - Bier SS (2010)
Bier SS, van Weyenberg SJ, Verheul HM, Mulder CJ, Cuesta MA, van der Peet DL. Niet-gemetastaseerd slokdarmcarcinoom; de chirurgische behandeling. Ned Tijdschr Geneeskd. 2010;154:A820.
 
640 - Biere SSAY (2009)
Biere SSAY, Cuesta MA, van der Peet DL. Minimally invasive versus open esophagectomy for cancer: a systematic review and meta-analysis. Minerva Chir. 2009;64(2):121-33.
 
641 - Birkmeyer NJO (2005)
Birkmeyer NJO, Goodney PP, Stukel TA, Hillner BE, Birkmeyer JD. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer. 2005;103(3):435-41.
 
642 - Bonavina L (2003)
Bonavina L, Incarbone R, Saino G, Clesi P, Peracchia A. Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. Dis. Esophagus. 2003;16(2):90-3.
 
643 - Bonnetain F (2006)
Bonnetain F, Bouche O, Michel P, Mariette C, Conroy T, Pezet D, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): Chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann. Oncol. 2006;17(5):827-34.
 
644 - Branagan G (2004)
Branagan G, Davies N. Early impact of centralization of oesophageal cancer surgery services. British Journal of Surgery. 2004;91(12):1630-2.
 
645 - Cao Y (2009)
Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy. 2009;41(9):751-7.
 
646 - Cao XF (2009)
Cao XF, He XT, Ji L, Xiao J, Lv J. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus. 2009;22(6):477-81.
 
647 - Chiu PWY (2005)
Chiu PWY, Chan ACW, Leung SF, Leong HT, Kwong KH, Li MKW, et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg. 2005;9(6):794-802.
 
648 - Chou S-H (2009)
Chou S-H, Chuang H-Y, Huang M-F, Lee C-H, Yau HM-P. A prospective comparison of transthoracic and transhiatal resection for esophageal carcinoma in Asians. Hepatogastroenterology. 2009;56(91-92):707-10.
 
649 - Conio M (2007)
Conio M, Repici A, Battaglia G, De Pretis G, Ghezzo L, Bittinger M, et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. American Journal of Gastroenterology. 2007;102(12):2667-77.
 
650 - Cunningham D (2006)
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11-20.
 
651 - de Boer AGEM (2004)
de Boer AGEM, van Lanschot JJB, van Sandick JW, Hulscher JBF, Stalmeier PFM, de Haes JCJM, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol. 2004;22(20):4202-8.
 
652 - Facey K (2007)
Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health technology assessment (Winchester, England). 2007 Oct;11(44):iii-iv, xi-267.
 
653 - Fang W (2001)
Fang W, Igaki H, Tachimori Y, Sato H, Daiko H, Kato H. Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age. Ann. Thorac. Surg. 2001;72(3):867-71.
 
654 - Ferlay J (2008)
Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-81.
 
655 - Ferlay J (2008)
Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-81
 
656 - Fiorica F (2004)
Fiorica F, Di Bona D, Schepis F, Licata A, Shahied L, Venturi A, et al. Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis. Gut. 2004;53(7):925-30.
 
657 - Gao F (2009)
Gao F, Jia L, Du H, Kuang X, Wang Y, Han J. A clinical study of combination of radiotherapy and IP regimen in the treatment of patients with local advanced esophageal cancer. Chinese-German Journal of Clinical Oncology. 2009;8(9):506-9.
 
658 - Gasper WJ (2009)
Gasper WJ, Glidden DV, Jin C, Way LW, Patti MG. Has recognition of the relationship between mortality rates and hospital volume for major cancer surgery in California made a difference?: A follow-up analysis of another decade. Annals of Surgery. 2009;250(3):472-83.
 
659 - Gebski V (2007)
Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncology. 2007;8(3):226-34.
 
660 - Gomi K (2003)
Gomi K, Oguchi M, Hirokawa Y, Kenjo M, Ogata T, Takahashi Y, et al. Process and preliminary outcome of a patterns-of-care study of esophageal cancer in Japan: Patients treated with surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2003;56(3):813-22.
 
661 - Goodney PP (2003)
Goodney PP, Stukel TA, Lucas FL, Finlayson EVA, Birkmeyer JD. Hospital volume, length of stay, and readmission rates in high-risk surgery. Ann Surg 2003;238(2):161-7.
 
662 - Graham AJ (2007)
Graham AJ, Shrive FM, Ghali WA, Manns BJ, Grondin SC, Finley RJ, et al. Defining the Optimal Treatment of Locally Advanced Esophageal Cancer: A Systematic Review and Decision Analysis. Ann Thorac Surg. 2007;83(4):1257-64.
 
663 - Green S (2009)
Green S, Tawil A, Barr H, Bennett C, Bhandari P, Decaestecker J, et al. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. Cochrane Database Syst Rev. 2009;2(2):CD007334.
 
664 - Gruen RL (2009)
Gruen RL, Pitt V, Green S, Parkhill A, Campbell D, Jolley D. The effect of provider case volume on cancer mortality: systematic review and meta-analysis. CA Cancer J Clin. 2009;59(3):192-211.
 
665 - Guo J-H (2008)
Guo J-H, Teng G-J, Zhu G-Y, He S-C, Fang W, Deng G, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology. 2008 May;247(2):574-81.
 
666 - Hjelms E (1999)
Hjelms E, Thirup P, Schou L. Gastric intrinsic factor production and vitamin B12 absorption after oesophageal resection using stomach as substitute. Eur J Cardiothorac Surg. 1999;16(3):273-5.
 
667 - Hogan BA (2008)
Hogan BA, Winter DC, Broe D, Broe P, Lee MJ Prospective trial comparing contrast swallow, computed tomography and endoscopy to identify anastomotic leak following oesophagogastric surgery. Surg Endosc. 2008 Mar;22(3):767-71. Epub 2007 Dec 11.
 
668 - Hongo M (2009)
Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729-35.
 
669 - Homs MYV (2006)
Homs MYV, v d Gaast A, Siersema PD, Steyerberg EW, Kuipers EJ. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction. Cochrane database of systematic reviews (Online). 2006;4(4):CD004063.
 
670 - Homs MY (2004)
Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004 Oct 23-29;364(9444):1497-504.
 
671 - Hulscher JBF (2002)
Hulscher JBF, van Sandick JW, de Boer AGEM, Wijnhoven BPL, Tijssen JGP, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347(21):1662-9.
 
672 - Ikcnet (2020)
www.ikcnet.nl/uploaded/docs/Landelijk/cijfers/incidentie%202007/A01_NL.xls.
 
673 - Ikcnet
http://www.ikcnet.nl/nieuws/index.php?id=5917).
 
674 - Ikcnet
http://www.ikcnet.nl/page.php?id=2616&nav_id=114).
 
675 - Ikcnet (2020)
http://www.ikcnet.nl/uploaded/docs/Landelijk/cijfers/incidentie%202007/A03_NL.xls).
 
676 - Ikcnet
http://www.ikcnet.nl/uploaded/FILES/Landelijk/cijfers/overleving/4.xls).
 
677 - Ioka A (2007)
Ioka A, Tsukuma H, Ajiki W, Oshima A. Hospital procedure volume and survival of cancer patients in Osaka, Japan: A population-based study with latest cases. Jpn J Clin Oncol. 2007;37(7):544-53.
 
678 - Ito H (2004)
Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, et al. Adenocarcinoma of the gastric cardia: What is the optimal surgical approach? J Am. Coll. Surg. 2004;199(6):880-6.
 
679 - Janssen-Heijnen ML (2005)
Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol. 2005;55:231-40.
 
680 - Jeganathan R (2009)
Jeganathan R, Kinnear H, Campbell J, Jordan S, Graham A, Gavin A, et al. A surgeon's case volume of oesophagectomy for cancer does not influence patient outcome in a high volume hospital. Interact Cardiovasc Thorac Surg. 2009;9(1):66-9.
 
681 - Jin H-L (2009)
Jin HL, Zhu H, Ling TS, Zhang HJ, Shi RH. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroenterol. 2009;15(47):5983-91.
 
682 - Johansson J (2008)
Johansson J, Djerf P, Oberg S, Zilling T, Von Holstein CS, Johnsson F, et al. Two different surgical approaches in the treatment of adenocarcinoma at the gastroesophageal junction. World J. Surg. 2008;32(6):1013-20.
 
683 - Jones R (2007)
Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ. 2007 May 19;334(7602):1040. Epub 2007 May 10.
 
684 - Jones R (2009)
Jones R, Wolfson, Charlton J, Latinovic R, Gulliford M. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ 2009;339:b3094
 
685 - Karlson BM (2000)
Karlson BM, Ekbom A, Wacholder S, McLaughlin JK, Hsing AW. Cancer of the upper gastrointestinal tract among patients with pernicious anemia: a case-cohort study. Scand J Gastroenterol. 2000;35(8):847-51.
 
686 - Kazui T (2007)
Kazui T, Osada H, Fujita H. An attempt to analyze the relation between hospital surgical volume and clinical outcome. Gen Thorac Cardiovasc Surg 2007;55(12):483-92.
 
687 - Kelsen DP (2007)
Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007;25(24):3719-25.
 
688 - Kim ES (2009)
Kim ES, Jeon SW, Park SY, Cho CM, Tak WY, Kweon YO, et al. Comparison of double-layered and covered Niti-S stents for palliation of malignant dysphagia. J Gastroenterol Hepatol 2009;24(1):114-9.
 
689 - Kinugasa S (2001)
Kinugasa S, Tachibana M, Yoshimura H, Dhar DK, Shibakita M, Ohno S, et al. Esophageal resection in elderly esophageal carcinoma patients: Improvement in postoperative complications. Ann. Thorac. Surg. 2001;71(2):414-8.
 
690 - Koppert LB (2004)
Koppert LB, Janssen-Heijnen ML, Louwman MW, Lemmens VE, Wijnhoven BP, Tilanus HW et al. Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study. Eur J Gastroenterol Hepatol. 2004;16:681-8).
 
691 - Kosugi S-I (2009)
Kosugi SI, Sasamoto R, Kanda T, Matsuki A, Hatakeyama K. Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older. Jpn J Clin Oncol. 2009;39(6):360-6.
 
692 - Kumar S (2007)
Kumar S, Dimri K, Khurana R, Rastogi N, Das KJM, Lal P. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Radiother Oncol 2007;83(2):139-47.
 
693 - Lagarde SM (2006)
Lagarde SM, ten Kate FJ, de Boer DJ, Busch OR, Obertop H, van Lanschot JJ. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Am J Surg Pathol. 2006;30:171-6.
 
694 - Lorenzen S (2009)
Lorenzen S, Schuster T, Porschen R, Al-Batran SE, Hofheinz R, Thuss-Patience P, et al. Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: A randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 2009;20(10):1667-73.
 
695 - Leigh Y (2009)
Leigh Y, Goldacre M, McCulloch P. Surgical specialty, surgical unit volume and mortality after oesophageal cancer surgery. Eur J Surg Oncol 2009;35(8):820-5.
 
696 - Lv J (2009)
Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol. 2009;15(39):4962-8.
 
697 - Malthaner RA (2006)
Malthaner RA, Collin S, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2006;Jul 19;3:CD001556.
 
698 - Mandard AM (1994)
Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994 Jun 1;73(11):2680-6.
 
699 - de Manzoni G (2004)
de Manzoni G, Pedrazzani C, Verlato G, Roviello F, Pasini F, Pugliese R, Cordiano C. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastrooesophageal junction. Br J Surg. 2004;91:296-303.
 
700 - Mattioli S (2001)
Mattioli S, Di Simone MP, Ferruzzi L, D'Ovidio F, Pilotti V, Carella R, et al. Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus. 2001;14(2):104-9.
 
701 - Meguid RA (2009)
Meguid RA, Weiss ES, Chang DC, Brock MV, Yang SC. The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence? J Thorac Cardiovasc Surg. 2009;137(1):23-9.
 
702 - Migliore M (2007)
Migliore M, Choong CK, Lim E, Goldsmith KA, Ritchie A, Wells FC. A surgeon's case volume of oesophagectomy for cancer strongly influences the operative mortality rate. Eur J Cardiothorac Surg 2007;32(2):375-80.
 
703 - Milne AA (2000)
Milne AA, Skinner J, Browning G. Centralisation of oesophageal cancer services; the view from the periphery. J Col Surg Edinb 2000;45(3):164-7.
 
704 - Minsky BD (2002)
Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167-74.
 
705 - Morita M (2008)
Morita M, Egashira A, Yoshida R, Ikeda K, Ohgaki K, Shibahara K, et al. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J. Gastroenterol. 2008;43(5):345-51.
 
706 - Nigro JJ (1999)
Nigro JJ, DeMeester SR, Hagen JA, DeMeester TR, Peters JH, Kiyabu M, et al. Node status in transmural esophageal denocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg. 1999; 117:960-8.
 
707 - Omloo JMT (2007)
Omloo JMT, Lagarde SM, Hulscher JBF, Reitsma JB, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246(6):992-1000; discussion -1.
 
708 - Omloo JM (2007)
Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal oesophagus. Ann Surg. 2007;246:992-1001).
 
709 - Omloo JM (2007)
Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, ten Kate FJ, Obertop H, Tilanus HW, van Lanschot JJ. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal oesophagus. Ann Surg. 2007;246:992-1001).
 
710 - Pan L (2009)
Pan L, Gu P, Huang G, Xue H, Wu S. Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis. Eur j Gastroenterol Hepatol 2009;21(9):1008-15.
 
711 - Post PN (2007)
Post PN, Siersema PD, van Dekken H. Rising incidence of clinically evident Barret’s oesophagus in the Netherlands: a nation-wide registry of pathology reports. Scand J Gastroenterol. 2007;42:17-22.
 
712 - Power C (2007)
Power C, Byrne PJ, Lim K, Ravi N, Moore J, Fitzgerald T, et al. Superiority of anti-reflux stent compared with conventional stents in the palliative management of patients with cancer of the lower esophagus and esophago-gastric junction: Results of a randomized clinical trial. Dis Esophagus. 2007;20(6):466-70.
 
713 - Rebollo Aguirre AC (2009)
Rebollo Aguirre AC, Ramos-Font C, Villegas Portero R, Cook GJR, Llamas Elvira JM, Tabares AR. 18F-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer: systematic review of the literature. Ann Surg. 2009;250(2):247-54.
 
714 - Rouvelas I (2007)
Rouvelas I, Jia C, Viklund P, Lindblad M, Lagergren J. Surgeon volume and postoperative mortality after oesophagectomy for cancer. Eur J Surg Oncol. 2007;33(2):162-8.
 
715 - Royal college of Pathologists
Royal college of Pathologists
 
716 - Rutegard M (2009)
Rutegard M, Lagergren J, Rouvelas I, Lagergren P. Surgeon volume is a poor proxy for skill in esophageal cancer surgery. Ann Surg 2009;249(2):256-61.
 
717 - Rutegard M (2008)
Rutegard M, Lagergren P. No influence of surgical volume on patients' health-related quality of life after esophageal cancer resection. Ann Surg Oncol. 2008;15(9):2380-7.
 
718 - Sabel MS (2002)
Sabel MS, Smith JL, Nava HR, Mollen K, Douglass HO, Gibbs JF. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol. 2002;9(2):210-4.
 
719 - Sabharwal T (2008)
Sabharwal T, Gulati MS, Fotiadis N, Dourado R, Botha A, Mason R, et al. Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: Proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction. J Gastroenterol Hepatol. 2008;23(5):723-8.
 
720 - Sasako M (2006)
Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7(8):644-51.
 
721 - Sharma N (2004)
Sharma N, Trope B, Lipman TO. Vitamin supplementation: what the gastroenterologist needs to know. J Clin Gastroenterol. 2004;38(10):844-54.
 
722 - Siewert JR (2000)
Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann. Surg. 2000;232(3):353-61.
 
723 - Siewert JR (1998)
Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85:1457-9.
 
724 - Smith BR (2008)
Smith BR, Hinojosa MW, Reavis KM, Nguyen NT. Outcomes of esophagectomy according to surgeon's training: general vs. thoracic. J Gastrointest Surg. 2008;12(11):1907-11.
 
725 - Sreedharan A (2009)
Sreedharan A, Harris K, Crellin A, Forman D, Everett SM. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005048.
 
726 - Stahl M (2009)
Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer H-J, Riera-Knorrenschild J, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27(6):851-6.
 
727 - Stahl M (2006)
Stahl M, Stuschke M, Lehmann N, Meyer H-J, Walz MK, Seeber S, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.[Erratum appears in J Clin Oncol. 2006 Jan 20;24(3):531]. J Clin Oncol. 2005;23(10):2310-7.
 
728 - Stitzenberg KB (2009)
Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009;27(28):4671-8.
 
729 - Sundelof M (2008)
Sundelof M, Lagergren J, Ye W. Surgical factors influencing outcomes in patients resected for cancer of the esophagus or gastric cardia. World J Surg. 2008;32(11):2357-65.
 
730 - Thirion PG (2007)
Thirion PG, Michiels S, Le Maitre A, Tierney J, on behalf of the MetaAnalysis of Chemotherapy in Esophagus Cancer Collaborative Group. Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma. J Clin Oncol (Meeting Abstracts). 2007;25(18suppl):4512.
 
731 - Vakil N (2006)
Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 2006;131:390-401.
 
732 - van Soest EM (2005)
van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett's oesophagus in the general population. Gut. 2005;54:1062-6.
 
733 - van Vliet EPM (2006)
van Vliet EPM, Eijkemans MJC, Kuipers EJ, Hermans JJ, Steyerberg EW, Tilanus HW, et al. A comparison between low-volume referring regional centers and a high-volume referral center in quality of preoperative metastasis detection in esophageal carcinoma. Am J Gastroenterol. 2006;101(2):234-42.
 
734 - van Vliet EPM (2006)
van Vliet EPM, Eijkemans MJC, Poley J-W, Steyerberg EW, Kuipers EJ, Siersema PD. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. Gastrointest Endosc. 2006;63(7):938-47.
 
735 - van Vliet EPM (2008)
van Vliet EPM, Hermans JJ, De Wever W, Eijkemans MJC, Steyerberg EW, Faasse C, et al. Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer. Eur Radiol. 2008;18(11):2475-84.
 
736 - Van Vliet EPM (2008)
Van Vliet EPM, Heijenbrok-Kal MH, Hunink MGM, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98(3):547-57.
 
737 - Van Westreenen HL (2007)
Van Westreenen HL, Westerterp M, Sloof GW, Groen H, Bossuyt PM, Jager PL et al. Limited additional value of positron emission tomography in staging oesophageal cancer. Br J Surg. 2007 Dec;94(12):1515-20.
 
738 - Verhage RJJ (2009)
Verhage RJJ, Hazebroek EJ, Boone J, Van Hillegersberg R. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chirurgica. 2009;64(2):135-46.
 
739 - Verhoef C (2007)
Verhoef C, van de Weyer R, Schaapveld M, Bastiaannet E, Plukker JTM. Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists. Ann Surg Oncol. 2007;14(5):1678-87.
 
740 - Verschuur EML (2008)
Verschuur EML, Repici A, Kuipers EJ, Steyerberg EW, Siersema PD. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: A randomized trial. Am J Gastroenterol. 2008;103(2):304-12.
 
741 - Verschuur EM (2009)
Verschuur EM, Steyerberg EW, Tilanus HW, Polinder S, Essink-Bot ML, Tran KT, van der Gaast A, Stassen LP, Kuipers EJ, Siersema PD. Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial. Br J Cancer 2009;100:70-6.
 
742 - Vidal-Alaball J (2005)
Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005(3):CD004655.
 
743 - Wenger U (2005)
Wenger U, Johnsson E, Bergquist H, Nyman J, Ejnell H, Lagergren J, et al. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: Results of a randomized clinical trial. Eur J Gastroenterol Hepatol. 2005;17(12):1369-77.
 
744 - Wenger U (2005)
Wenger U, Luo J, Lundell L, Lagergren J. A nationwide study of the use of self-expanding stents in patients with esophageal cancer in Sweden. Endoscopy. 2005;37(4):329-34.
 
745 - Wiersinga WJ (2005)
Wiersinga WJ, de Rooij SE, Huijmans JGM, Fischer C, Hoekstra JBL. Diagnosis of vitamin B12 deficiency revised. Ned Tijdschr Geneeskd. 2005 Dec 10;149(50):2789-94.
 
746 - Wong R (2006)
Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database of Systematic Reviews. 2006;1(1):CD002092.
 
747 - Wouters MW (2008)
Wouters MW, Wijnhoven BP, Karim-Kos HE, Blaauwgeers HG, Stassen LP, Steup W-H, et al. High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol. 2008;15(1):80-7.
 
748 - Wouters MWJM (2009)
Wouters MWJM, Karim-Kos HE, le Cessie S, Wijnhoven BPL, Stassen LPS, Steup WH, et al. Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann Surg Oncol. 2009;16(7):1789-98. (a)
 
749 - Wouters MWJM (2009)
Wouters MWJM, Krijnen P, Le Cessie S, Gooiker GA, Guicherit OR, Marinelli AWKS, et al. Volume- or outcome-based referral to improve quality of care for esophageal cancer surgery in The Netherlands. J Surg Oncol. 2009;99(8):481-7. (b)
 
750 - Wright CD (2009)
Wright CD, Kucharczuk JC, O'Brien SM, Grab JD, Allen MS, Society of Thoracic Surgeons General Thoracic Surgery D. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. J Thorac Cardiovasc Surg. 2009;137(3):587-95; discussion 96.
 
751 - Yadav BS (2007)
Yadav BS, Kapoor R, Sharma SC, Kochhar R, Patel FD. Radiation schedules for palliation in carcinoma esophagus. JK Science. 2007;9(3):127-31.
 
752 - Yakoub D (2008)
Yakoub D, Fahmy R, Athanasiou T, Alijani A, Rao C, Darzi A, et al. Evidence-based choice of esophageal stent for the palliative management of malignant dysphagia. World Journal of Surgery. 2008 Sep 32(9):1996-2009.
 
753 - Ye W (2003)
Ye W, Nyren O. Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut. 2003;52(7):938-41.
 
754 - Enzinger PC (2003)

Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003 Dec 4;349(23):2241-52.

 
755 - Le Prisé EL (1998)

Le Prisé EL. Cancer of the esophagus: outcome of neoadjuvant therapy on surgical morbidity and mortality. Cancer Radiother. 1998 Dec;2(6):763-70.

 
756 - Boone J (2008)

Boone J. Rinkes IB, van Leeuwen M, van Hilliegersberg R. Diagnostic value of routine aqueous contrast swallow examination after oesophagectomy for detecting leakage of the cervical oesophagogastric anastomosis. ANZ J Surg. 2008 Sep;78(9):784-90

 
757 - Tirnaksiz MB (2005)
Tirnaksiz MB, Deschamps C, Allen MS, Johnson DC, Pairolero PC. Effectiveness of screening aqueous contrast swallow in detecting clinically significant anastomotic leaks after esophagectomy. Eur Surg Res. 2005 Mar-Apr;37(2):123-8.
 
758 - Chau I (2009)
Chau I, Norman AR, Cunningham D, Oates J, Hawkins R, Iveson T, Nicolson M, Harper P, Seymour M, Hickish T. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials. Ann Oncol. 2009 May;20(5):885-91. Epub 2009 Jan 22.
 
759 - Polee MB (2003)

Polee MB, Hop WC, Kok TC, Eskens FA, van der Burg ME, Splinter TA, et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer. 2003 Dec 1;89(11):2045-50

 
760 - Buise M (2008)
Buise M, Van Bommel J, Mehra M, Tilanus HW, Van Zundert A, Gommers D. Pulmonary morbidity following esophagectomy is decreased after introduction of a multimodal anesthetic regimen. Acta Anaesthesiol Belg. 2008;59(4):257-61
 
761 - Hafidh SA (2007)
Hafidh SA, Reuter MD, Chassels LJ, Aradhyula S, Bhutto SS, Alpert MA. Effect of intravenous insulin therapy on clinical outcomes in critically ill patients. Am J Med Sci. 2007 Jun;333(6):354-61
 
762 - Kao LS (2009)
Kao LS, Perioperative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006806.
 
763 - Nishimori M (2006)
Nishimori M, Ballantyne JC, Low JH. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev. 2006 Jul 19;3:CD005059.
 
764 - Pöpping DM (2008)
Pöpping DM, Elia N, Marret E, Remy C, Tramèr MR. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg. 2008 Oct;143(10):990-9; discussion 1000.
 
765 - de Smet (2009)
de Smet, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. NEJM 2009 Jan 1;360(1):20-31
 
766 - Fockens P (1996)
Fockens P, van den Brande JHM, van Dullemen HM, van Lanschot JJB, Tytgat GNJ. Endosonographic T-staging of Esophageal carcinoma: a learning curve. Gastrointest Endosc 1996;44:58-62.
 
767 - Boonstra JJ

Boonstra JJ, Kok TC, Wijnhoven BP et al. Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial. BMC Cancer. 2011 May 19;11:181. doi: 10.1186/1471-2407-11-181.

 

 

 
768 - Burmeister

Burmeister BH, Thomas JM, Burmeister EA, et al. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer. 2011 Feb;47(3):354-60. doi: 10.1016/j.ejca.2010.09.009.

 

 

 
769 - Lv J 2010

Lv J, Cao XF, Zhu B, Ji L, et al. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma.

World J Gastroenterol. 2010 Apr 7;16(13):1649-54.

 
770 - van Hagen P 2012

van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.

 
771 - Vogt 2006
Vogt K, Fenlon D et al. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database of Systematic Reviews(3) 2006.
 
772 - Xu XH 2012

Xu XH, Peng XH, Yu P, Xu XY, et al. Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials. Asian Pac J Cancer Prev. 2012;13(1):103-10.

 
773 - Ychou M 2011

Ychou M, Boige V, Pignon JP, Conroy T, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011 May 1;29(13):1715-21. doi: 10.1200/JCO.2010.33.0597. Epub 2011 Mar 28.

 

 
774 - Al-Refaie WB 2012

Al-Refaie WB, Muluneh B, Zhong W, Parsons HM, Tuttle TM, Vickers SM, et al. Who receives their complex cancer surgery at low-volume hospitals? J Am Coll Surg. 2012 Jan;214(1):81-7. doi: 10.1016/j.jamcollsurg.2011.10.003. Epub 2011 Nov 23.

 
775 - Bilimoria KY 2010
Bilimoria KY, Bentrem DJ, Talamonti MS, Stewart AK, Winchester DP, Ko CY. Risk-based selective referral for cancer surgery: A potential strategy to improve perioperative outcomes. Ann. Surg. 2010;251(4):708-16.
 
776 - Boddy AP 2012
Boddy AP, Williamson JML, Vipond MN. The effect of centralisation on the outcomes of oesophagogastric surgery - A fifteen year audit. Int J Surg. 2012;10(7):360-3. doi: 10.1016/j.ijsu.2012.05.012. Epub 2012 May 30.
 
777 - Cheung MC 2010
Cheung MC, Koniaris LG, Yang R, Zhuge Y, Mackinnon JA, Byrne MM, et al. Do all patients with carcinoma of the esophagus benefit from treatment at teaching facilities? J Surg Oncol. 2010 Jul 1;102(1):18-26. doi: 10.1002/jso.21509.
 
778 - Coupland VH 2013
Coupland VH, Lagergren J, Luchtenborg M, Jack RH, Allum W, Holmberg L, et al. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: A population-based study in England, 2004-2008. Gut. 2013 Jul;62(7):961-6. doi: 10.1136/gutjnl-2012-303008. Epub 2012 Oct 19.. [Epub ahead of print]
 
779 - Dikken JL 2012
Dikken JL, Dassen AE, Lemmens VEP, Putter H, Krijnen P, Van Der Geest L, et al. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur J Cancer. 2012 May;48(7):1004-13. doi: 10.1016/j.ejca.2012.02.064. Epub 2012 Mar 27.
 
780 - Dikken JL 2012
Dikken JL, Wouters MWJM, Lemmens VEP, Putter H, van der Geest LGM, Verheij M, et al. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery. Br J Surg. 2012 Jul;99(7):954-63. doi: 10.1002/bjs.8787. Epub 2012 May 9.
 
781 - Dikken JL 2013
Dikken JL, van Sandick JW, Allum WH, Johansson J, Jensen LS, Putter H, et al. Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg. 2013 Jan;100(1):83-94. doi: 10.1002/bjs.8966. Epub 2012 Nov 23.
 
782 - Finks JF 2011
Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011 Jun 2;364(22):2128-37. doi: 10.1056/NEJMsa1010705.
 
783 - Ghaferi AA 2011
Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and failure to rescue with high-risk surgery. Med Care. 2011 Dec;49(12):1076-81. doi: 10.1097/MLR.0b013e3182329b97.
 
784 - Markar SR 2012
Markar SR, Karthikesalingam A, Thrumurthy S, Low DE. Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011. J Gastrointest Surg. 2012;16(5):1055-63. doi: 10.1007/s11605-011-1731-3. Epub 2011 Nov 17.
 
785 - Sakata R 2012
Sakata R, Kuwano H, Yokomise H. Hospital volume and outcomes of cardiothoracic surgery in Japan: 2005-2009 National survey. Gen. Thorac. Gen Thorac Cardiovasc Surg. 2012 Oct;60(10):625-38. doi: 10.1007/s11748-012-0128-x.
 
786 - Wouters MWJM 2012
Wouters MWJM, Gooiker GA, Van Sandick JW, Tollenaar RAEM. The volume-outcome relation in the surgical treatment of esophageal cancer: A systematic review and meta-analysis. Cancer. 2012 Apr 1;118(7):1754-63. doi: 10.1002/cncr.26383. Epub 2011 Aug 25.
 
787 - Chao YK 2012
Chao YK, Chuang WY, Yeh CJ, et al. Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients. J Surg Oncol. 2012 Feb;105(2):183-8. doi: 10.1002/jso.22068. Epub 2011 Aug 30.

 

 
788 - Chao YK 2011
Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ et al. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma. Ann Surg Oncol 2011 February;18(2):529-34.
 
789 - Deeter M 2009
Deeter M, Dorer R, Kuppusamy MK, Koehler RP, Low DE. Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer. Arch Surg. 2009 Jul;144(7):618-24. doi: 10.1001/archsurg.2009.115.
 
790 - Dexter SP 2001

Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001 May;48(5):667-70

 
791 - Griffiths EA
Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM. The prognostic value of circumferential resection margin involvement in oesophageal malignancy. Eur J Surg Oncol 2006 May;32(4):413-9.
 
792 - Han D 2012
Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, et al. Comparison of the diagnostic value of 3-deoxy-3-(18) F-fluorothymidine and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Dis Esophagus. 2012;25(5):416-26.
 
793 - Hu Q 2009
Hu Q, Wang W, zhong X, Yuan S, Fu Z, Guo H, et al. Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer. Eur J Radiol. 2009 May;70(2):320-4.
 
794 - Noble F 2009
Noble F, Bailey D, Panel SUGT, Tung K, Byrne JP. Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study. Clin Radiol. 2009;64(7):699-705.
 
795 - Okada M 2009

Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, et al. Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med. 2009 Jan;23(1):73-80.

 
796 - Wong R 2012

Wong R, Walker-Dilks C, Raifu A. Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Oesophageal Cancer. Clin Oncol (R Coll Radiol). 2012 Mar;24(2):86-104.

 
797 - Yu W 2011
Yu W, Fu X-L, Zhang Y-J, Xiang J-Q, Shen L, Chang JY. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus. Int J Radiat Oncol Biol Phys. 2011;81(5):e759-65
 
798 - Agarwal B 2004
Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, et al. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol. 2004;99(7):1258-66.
 
799 - Blom 2011
Blom RLGM, Schreurs WMJ, Belgers HJ, Oostenbrug LE, Vliegen RFA, Sosef MN. The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma. Eur J Surg Oncol. 2011 Sep;37(9):774-8
 
800 - Chen 2011
Chen YM, Pan XF, Tong LJ, Shi YP, Chen T. Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis. Nucl Med Commun. 2011 Nov;32(11):1005-10.
 
801 - gillies 2012
Gillies RS, Middleton MR, Blesing C, Patel K, Warner N, Marshall REK, et al. Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer. Eur Radiol. 2012 Sep;22(9):2035-43.
 
802 - Griffin 2012
Griffin JM, Reed CE, Denlinger CE. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer. Ann Thorac Surg. 2012;93(6):1855-9; discussion 60.
 
803 - Kalha 2004
Kalha I, Kaw M, Fukami N, Patel M, Singh S, Gagneja H, et al. The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Cancer. 2004 Sep 1;101(5):940-7.
 
804 - Kauppa 2012
Kauppi JT, Oksala N, Salo JA, Helin H, Karhumaki L, Kemppainen J, et al. Locally advanced esophageal adenocarcinoma: Response to neoadjuvant chemotherapy and survival predicted by 18F FDG-PET/CT. Acta Oncol. 2012;51(5):636-44.
 
805 - Kwee 2010
Kwee RM. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review. Radiology 2010;254(3):707-17.
 
806 - Misra S 2012
Misra S, Choi M, Livingstone AS, Franceschi D. The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer. Surg Endosc. 2012 Feb;26(2):518-22
 
807 - Ngamruengphong S 2010
Ngamruengphong S, Sharma VK, Nguyen B, Das A. Assessment of response to neoadjuvant therapy in esophageal cancer: An updated systematic review of diagnostic accuracy of endoscopic ultrasonography and fluorodeoxyglucose positron emission tomography. Dis Esophagus. 2010 Apr;23(3):216-31
 
808 - Owaki T 2012

Owaki T, Matsumoto M, Okumura H, Uchicado Y, Kita Y, Setoyama T, et al. Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma. Am J Surg. 2012 Feb;203(2):191-7.

 

 
809 - Ribeiro A, 2006

Ribeiro A, Franceschi D, Parra J, Livingstone A, Lima M, Hamilton-Nelson K, et al. Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol. 2006 Jun;101(6):1216-21.

 

 
810 - Schneider PM 2008
Schneider PM, Metzger R, Schaefer H, Baumgarten F, Vallbohmer D, Brabender J, et al. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer. Ann Surg. 2008 Dec;248(6):902-8.
 
811 - Van Heijl M 2011
Van Heijl M, Omloo JM, Van Berge Henegouwen MI, Hoekstra OS, Boellaard R, Bossuyt PM, et al. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann Surg. 2011 Jan;253(1):56-63.
 
812 - Van Heijl M, 2011
Van Heijl M, Phoa SSKS, Van Berge Henegouwen MI, Omloo JMT, Mearadji BM, Sloof GW, et al. Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer. Eur J Surg Oncol. 2011 Dec;37(12):1064-71
 
813 - Westerterp M 2005
Westerterp M, Van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, et al. Esophageal cancer: CT, endoscopie US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review. Radiology. 2005 Sep;236(3):841-51.
 
814 - Yen TJ 2012
Yen TJ, Chung CS, Wu YW, Yen RF, Cheng MF, Lee JM, et al. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma. Dis Esophagus. 2012 Jan;25(1):40-7.
 
815 - Zum Buschenfelde CM 2011
Zum Buschenfelde CM, Herrmann K, Schuster T, Geinitz H, Langer R, Becker K, et al. 18F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: The MUNICON II trial. J Nucl Med. 2011 Aug;52(8):1189-96.
 
816 - Chao YK 2011

Chao YK, Yeh CJ, Chang HK, Tseng CK, Chu YY, Hsieh MJ et al. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma. Ann Surg Oncol 2011 February;18(2):529-34.

 
817 - Deeter M 2009
Deeter \m, Dorer R, Kuppusamy MK, Koehler RP, Low DE. Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer. Arch Surg 2009 July;144(7):618-24.
 
818 - Dexter SP
Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001 May;48(5):667-70
 
819 - Harvin JA 2012
Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J et al. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 2012 February;143(2):412-20
 
820 - Khan OA 2003
Khan OA, Fitzgerald JJ, Soomro I, Beggs FD, Morgan WE, Duffy JP. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer 2003 May 19;88(10):1549-52.
 
821 - Mirnezami R 2010
Mirnezami R, Rohatgi A, Sutcliffe RP, Hamouda A, Chandrakumaran K, Botha A et al. Multivariate analysis of clinicopathological factors influencing survival following esophagectomy for cancer. Int J Surg 2010;8(1):58-63.
 
822 - Rao VS 2012
Rao VS, Yeung MM, Cooke J, Salim E, Jain PK. Comparison of circumferential resection margin clearance criteria with survival after surgery for cancer of esophagus. J Surg Oncol 2012 June 15;105(8):745-9.
 
823 - Reid TD 2012
Reid TD, Chan DS, Roberts SA, Crosby TD, Williams GT, Lewis WG. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer and the predictive role of endoluminal ultrasonography. Br J Cancer 2012 December 4;107(12):1925-31.
 
824 - Sagar PM
Sagar PM, Johnston D, McMahon MJ, Dixon MF, Quirke P. Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg 1993 November;80(11):1386-8.
 
825 - Saha AK 2009
Saha AK, Sutton C, Rotimi O, Dexter S, Sue-Ling H, Sarela AI. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category. Ann Surg Oncol 2009 May;16(5):1364-70.
 
826 - Salih T 2013
Salih T, Jose P, Mehta SP, Mirza A, Udall G, Pritchard SA et al. Prognostic significance of cancer within 1 mm of the circumferential resection margin in oesophageal cancer patients following neo-adjuvant chemotherapy. Eur J Cardiothorac Surg. 2013 Mar;43(3):562-7
 
827 - Scheepers JJ 2009
Scheepers JJ, van der Peet DL, Veenhof AA, Cuesta MA. Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route. Dis Esophagus 2009;22(1):42-8.
 
828 - Sillah K 2009
Sillah K, Pritchard SA, Watkins GR, McShane J, West CM, Page R et al. The degree of circumferential tumour involvement as a prognostic factor in oesophageal cancer. Eur J Cardiothorac Surg 2009 August;36(2):368-73.
 
829 - Sujendran V 2008
Sujendran V, Wheeler J, Baron R, Warren BF, Maynard N. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg 2008 February;95(2):191-4
 
830 - Suttie SA 2012
Suttie SA, Nanthakumaran S, Mofidi R, Rapson T, Gilbert FJ, Thompson AM et al. The impact of operative approach for oesophageal cancer on outcome: the transhiatal approach may influence circumferential margin involvement. Eur J Surg Oncol 2012 February;38(2):157-65.
 
831 - Verhage RJ 2011
Verhage RJ, Zandvoort HJ, ten Kate FJ, van HR. How to define a positive circumferential resection margin in T3 adenocarcinoma of the esophagus. Am J Surg Pathol 2011 June;35(6):919-26.
 
832 - Zafirellis K 2002
Zafirellis K, Dolan K, Fountoulakis A, Dexter SP, Martin IG, Sue-Ling HM. Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy? Dis Esophagus 2002;15(2):155-9.
 
833 - Al-Refaie WB 2012
Al-Refaie WB, Muluneh B, Zhong W, Parsons HM, Tuttle TM, Vickers SM, et al. Who receives their complex cancer surgery at low-volume hospitals? J Am Coll Surg. 2012 Jan;214(1):81-7
 
834 - Bilimoria KY 2010
Bilimoria KY, Bentrem DJ, Talamonti MS, Stewart AK, Winchester DP, Ko CY. Risk-based selective referral for cancer surgery: A potential strategy to improve perioperative outcomes. Ann Surg. 2010 Apr;251(4):708-16. .
 
835 - Boddy AP 2012
Boddy AP, Williamson JML, Vipond MN. The effect of centralisation on the outcomes of oesophagogastric surgery - A fifteen year audit. Int J Surg. 2012;10(7):360-3.
 
836 - Cheung MC 2010
Cheung MC, Koniaris LG, Yang R, Zhuge Y, Mackinnon JA, Byrne MM, et al. Do all patients with carcinoma of the esophagus benefit from treatment at teaching facilities? J Surg Oncol. 2010 Jul 1;102(1):18-26.
 
837 - Coupland VH 2013
Coupland VH, Lagergren J, Luchtenborg M, Jack RH, Allum W, Holmberg L, et al. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: A population-based study in England, 2004-2008. Gut. 2013 Jul;62(7):961-6. [Epub ahead of print]
 
838 - Dikken 2012
Dikken JL, Dassen AE, Lemmens VEP, Putter H, Krijnen P, Van Der Geest L, et al. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur. J. Cancer. 2012;48(7):1004-13.
 
839 - Dikken JL 2012
Dikken JL, Wouters MWJM, Lemmens VEP, Putter H, van der Geest LGM, Verheij M, et al. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery. Br J Surg. 2012;99(7):954-63.
 
840 - Dikken JL 2013
Dikken JL, van Sandick JW, Allum WH, Johansson J, Jensen LS, Putter H, et al. Differences in outcomes of oesophageal and gastric cancer surgery across Europe. Br J Surg. 2013 Jan;100(1):83-94.
 
841 - Finks JF 2011
Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011 Jun 2;364(22):2128-37
 
842 - Ghaferi AA 2011
Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and failure to rescue with high-risk surgery. Med Care. 2011 Dec;49(12):1076-81.
 
843 - Markar DR 2012
Markar SR, Karthikesalingam A, Thrumurthy S, Low DE. Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011. J Gastrointest Surg. 2012;16(5):1055-63.
 
844 - Sakata R 2012
Sakata R, Kuwano H, Yokomise H. Hospital volume and outcomes of cardiothoracic surgery in Japan: 2005-2009 National survey. Gen Thorac Cardiovasc Surg. 2012 Oct;60(10):625-38.
 
845 - Wouters MWJM 2012
Wouters MWJM, Gooiker GA, Van Sandick JW, Tollenaar RAEM. The volume-outcome relation in the surgical treatment of esophageal cancer: A systematic review and meta-analysis. Cancer. 2012 Apr 1;118(7):1754-63